Malignant neoplasm of pancreas

C3_PANCREAS

Malignant Pancreatic Neoplasm: A primary or metastatic malignant tumor involving the pancreas. Representative examples include carcinoma and lymphoma. -- 2003

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Cause of death: ICD-10 — C25 Cause of death: ICD-9 — 157 Cause of death: ICD-8 — 157 Cancer registry: Topography ICD-O-3 — C25 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 2 out of 7 registries used, show all original rules.	3421
4. Check minimum number of events None	3421
5. Include endpoints None	3421
6. Filter based on genotype QC (FinnGen only)	3048

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF9

NAME	C3_PANCREAS
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C25
COD_ICD_9	157
COD_ICD_8	157
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C25
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of pancreas based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3048	1282	1766
Unadjusted period prevalence (%)	0.66	0.46	0.81
Median age at first event (years)	71.81	71.68	71.90

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3135: Matched controls
31350

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

3258.1

322.3

306

WF002

NOMESCO Finland

Radical radiotherapy

78.6

320.0

171

D76

ICPC

Malignant neoplasm pancreas

1132.5

319.3

307

C25.2

ICD-10 Finland

Malignant neoplasm: Tail of pancreas

+∞

307.7

408

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

50.8

307.7

540

128

JN3AD

NOMESCO Finland

Abdominal CT examination

5.5

307.7

871

2047

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

118.1

307.7

539

A04AA02

ATC

granisetron; systemic, transdermal

1553.2

307.7

969

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

2040

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

307.7

1407

Z51.5

ICD-10 Finland

Palliative care

31.1

307.7

1447

841

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

307.7

623

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

33.2

307.7

231

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

307.7

541

JLC30

NOMESCO Finland

Pancreatoduodenectomy

1898.7

307.7

472

TPX10

NOMESCO Finland

Implantation of vascular injection port

15.9

307.7

339

237

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

33.9

307.7

224

JN4BD

NOMESCO Finland

Extensive body CT

10.8

307.7

607

680

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

17.4

307.7

358

231

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

30.6

307.7

292

105

JN4CD

NOMESCO Finland

Very extensive body CT

24.8

307.7

358

162

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

73.6

307.7

1073

220

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

5200.4

307.7

808

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

82.3

307.7

186

L03AA02

ATC

filgrastim; parenteral

252.8

307.7

234

A04AA01

ATC

ondansetron; systemic, rectal

27.2

307.7

713

336

A03FA01

ATC

metoclopramide; systemic, rectal

22.1

307.7

1845

1903

JK3BT

NOMESCO Finland

Catherisation of bile duct with X-ray guidance

112.3

307.7

190

UJK02

NOMESCO Finland

ERCP

25.6

307.7

716

359

JN4AD

NOMESCO Finland

Body CT examination

12.0

307.7

907

1026

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

20.6

307.7

374

205

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

1698.3

307.7

559

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

35.0

307.7

459

153

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

27.2

307.7

422

178

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

17.5

307.7

597

416

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

126.0

307.7

907

101

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

+∞

307.7

799

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

+∞

307.7

822

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

+∞

307.7

522

H02AB02

ATC

dexamethasone; systemic

126.7

307.7

1182

149

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

120.2

307.7

1228

167

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

140.6

307.7

372

R4190

NOMESCO Finland

Nutritional therapy

16.9

307.7

369

245

A06AH03

ATC

naloxegol; oral

50.2

307.7

254

N02AA05

ATC

oxycodone; systemic

12.1

307.7

1830

3254

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

307.7

1759

K83.1

ICD-10 Finland

Obstruction of bile duct

86.4

307.7

585

L01BC06

ATC

capecitabine; oral

+∞

307.7

641

C25.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of pancreas

+∞

307.7

324

WX302

NOMESCO Finland

Thoracal epidural anesthesy

24.1

307.7

549

274

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

21.2

303.3

231

117

WZC00

NOMESCO Finland

Treatment plan or consultation

3.9

303.1

1413

5409

K83.0

ICD-10 Finland

Cholangitis

17.1

300.0

254

161

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

7.9

295.5

440

637

JAH01

NOMESCO Finland

Laparoscopy

10.7

292.3

333

344

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

69.9

281.2

153

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

2616.2

264.2

252

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

5.5

262.1

578

1235

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

106.8

258.5

133

R18

ICD-10 Finland

Ascites

14.4

251.3

233

174

8140/3-C25.0

ICD-O-3

Adenocarcinoma, NOS, of head of pancreas

+∞

244.0

231

JK3NB

NOMESCO Finland

Percutaneous transhepatic cholangiography

82.7

239.3

127

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

2281.4

233.1

223

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

6.1

228.8

436

810

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

226.9

215

A04AA55

ATC

palonosetron, combinations; systemic

+∞

219.4

208

L03AA13

ATC

pegfilgrastim; parenteral

1135.2

219.4

212

B01AB10

ATC

tinzaparin; parenteral

4.9

214.3

541

1287

WZC30

NOMESCO Finland

Teaching

4.0

205.7

709

2133

WW500

NOMESCO Finland

Blood transfusion

10.3

203.5

234

243

JMA10

NOMESCO Finland

Transabdominal total splenectomy

57.5

197.3

111

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

197.0

187

8000/3-C25.0

ICD-O-3

Neoplasm, malignant of head of pancreas

+∞

188.5

179

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

249.9

184.7

188

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

7.9

182.3

260

354

JKE22

NOMESCO Finland

Endoscopic extraction of foreign body from bile duct

33.4

181.1

116

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

181.0

172

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.7

180.9

689

2205

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

177.8

169

C61

ICD-10 Finland

Malignant neoplasm of prostate

212.1

175.0

180

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

12.4

173.8

175

149

D13.6

ICD-10 Finland

Benign neoplasm: Pancreas

23.2

171.9

125

8500/3-C25.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of pancreas, NOS

+∞

171.4

163

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

28.3

165.8

112

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

10.7

165.3

184

182

JN3BD

NOMESCO Finland

Extensive abdominal CT

4.1

158.7

497

1380

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.5

155.3

625

2058

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

154.5

147

JLC10

NOMESCO Finland

Distal pancreatectomy

182.3

150.1

156

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

28.9

146.2

A10AB05

ATC

insulin aspart; parenteral

3.9

146.1

498

1464

JL1AT

NOMESCO Finland

Biopsy of pancreas with ultrasound guidance

1495.5

146.0

141

XX3DW

NOMESCO Finland

Time consuming IT work

5.2

141.3

311

651

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

19.6

141.0

110

JK4ZT

NOMESCO Finland

Percutaneous transhepatic implantation of bile duct prothesis

714.4

140.0

137

R50.9

ICD-10 Finland

Fever, unspecified

3.2

138.8

680

2514

C25

ICD-10 Finland

Malignant neoplasm of pancreas

+∞

138.6

132

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

31.9

134.1

C25.4

ICD-10 Finland

Malignant neoplasm: Endocrine pancreas

+∞

131.2

125

JK3NT

NOMESCO Finland

Percutaneous transhepatic dilatation of bileducts

72.6

131.1

L02AE02

ATC

leuprorelin; implant, parenteral

52.6

125.7

JDE00

NOMESCO Finland

Gastrojejunostomy

264.8

125.0

127

A10AE04

ATC

insulin glargine; parenteral

3.2

121.3

574

2066

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

18.2

120.2

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

14.3

118.9

109

SPAT1109

SPAT

Analgesia with portable analgesic pump

24.6

118.5

115

Kela drug reimbursment

Breast cancer

+∞

116.4

111

WF049

NOMESCO Finland

Radiotherapy of metastasis

303.0

114.9

116

B01AB05

ATC

enoxaparin; parenteral

2.4

114.7

1155

6083

ZX120

NOMESCO Finland

Intravenous

3.8

113.2

374

1068

B01AB04

ATC

dalteparin; parenteral

4.6

113.1

284

661

WX004

NOMESCO Finland

Patient-controlled sedation

25.3

112.6

116

Kela drug reimbursment

Prostate cancer

+∞

110.0

105

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

49.4

108.5

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

7.3

108.4

163

234

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

107.9

103

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

19.6

107.8

A79

ICPC

Malignancy NOS

221.5

104.2

107

A04AD12

ATC

aprepitant; systemic

519.5

102.2

101

JAH00

NOMESCO Finland

Laparotomy

6.2

101.4

179

304

JN5ER

NOMESCO Finland

PET-CT of receptors in whole body

56.0

97.0

8500/3-C25.0

ICD-O-3

Infiltrating duct carcinoma, NOS, of head of pancreas

+∞

96.3

TPH07

NOMESCO Finland

Cathetrisation of artery

2.9

95.3

508

1939

L02BG04

ATC

letrozole; oral

29.2

94.4

WX610

NOMESCO Finland

Patient controlled analgesia

23.1

93.7

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

27.2

93.6

H01CB03

ATC

lanreotide; parenteral

471.4

92.8

JLC11

NOMESCO Finland

Laparoscopic distal pancreatectomy

195.9

91.8

PHN73

NOMESCO Finland

Reconstruction of superior mesenteric or portal vein

+∞

91.1

D70.82

ICD-10 Finland

Drug-induced neutropenia

22.9

89.2

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

9.2

88.2

108

121

WPB10

NOMESCO Finland

Making a convalescent care decision

32.2

88.1

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

86.9

J01MA12

ATC

levofloxacin; systemic

2.4

86.1

753

3653

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

28.1

85.8

PJA12

NOMESCO Finland

Sentinel node biopsy

851.0

85.0

L01AX03

ATC

temozolomide; systemic

+∞

84.8

WX402

NOMESCO Finland

General anaesthesia

2.5

84.1

648

2964

TPH04

NOMESCO Finland

Cathetrisation of vein

2.3

83.6

819

4167

103

Kela drug reimbursment

Diabetes, insulin-treated

2.1

83.2

1235

7404

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

8.4

82.7

109

134

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

80.6

1176

6986

8140/3-C25.2

ICD-O-3

Adenocarcinoma, NOS, of tail of pancreas

+∞

79.5

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.4

79.0

675

3228

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

397.2

78.2

8240/3-C25.9

ICD-O-3

Neuroendocrine tumor, NOS, of pancreas, NOS

+∞

77.4

ZX122

NOMESCO Finland

Intra-arterial

18.8

77.0

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

76.4

K86.9

ICD-10 Finland

Disease of pancreas, unspecified

13.4

75.1

A02BC02

ATC

pantoprazole; systemic

2.1

73.1

2214

16825

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

72.2

K85.8

ICD-10 Finland

Other acute pancreatitis

10.8

71.8

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

10.6

71.1

ZX121

NOMESCO Finland

Central venous catheter

37.2

70.7

N02AX02

ATC

tramadol; systemic, rectal

1.9

70.5

1456

9658

XX2RW, ,

NOMESCO Finland

12.3

70.3

191

Kela drug reimbursment

Erlotinib

+∞

70.1

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

34.3

69.1

8010/3-C25.9

ICD-O-3

Carcinoma, NOS, of pancreas, NOS

+∞

69.0

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

69.0

K86.8

ICD-10 Finland

Other specified diseases of pancreas

17.8

68.9

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

5.8

68.5

128

229

WW200, ,

SPAT

0.3

68.2

267

6844

JK3SB

NOMESCO Finland

Endoscopic retrorade cholangiography

23.2

66.2

WF004

NOMESCO Finland

Palliative radiotherapy

661.9

66.2

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

5.2

66.1

140

281

HAB40

NOMESCO Finland

Wedge excision of mammary gland

16.3

65.9

WPA13

NOMESCO Finland

Palliative consultation

17.4

64.4

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

63.8

A06AD11

ATC

lactulose; oral

2.2

63.4

698

3672

8249/3-C25.9

ICD-O-3

Neuroendocrine tumor, grade 2 of pancreas, NOS

+∞

62.7

JL2AT

NOMESCO Finland

Cytology of pancreas with ultrasound guidance

620.2

62.0

E13.8

ICD-10 Finland

Other specified diabetes mellitus, with unspecified complications

20.7

61.9

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.6

61.7

210

606

N02AA01

ATC

morphine; systemic, rectal

5.8

61.6

114

202

1CD01, ,

NOMESCO Finland

+∞

60.6

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

59.7

1050

6512

C25.7

ICD-10 Finland

Malignant neoplasm: Other parts of pancreas

+∞

59.6

D13.7

ICD-10 Finland

Benign neoplasm: Endocrine pancreas

207.3

59.3

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

9.8

57.5

8140/3-C25.1

ICD-O-3

Adenocarcinoma, NOS, of body of pancreas

+∞

56.4

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

4.0

55.4

163

425

K86.1

ICD-10 Finland

Other chronic pancreatitis

7.2

55.1

116

JLC40

NOMESCO Finland

Total pancreatoduodenectomy

281.1

54.3

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.6

54.3

188

548

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.9

54.1

956

5901

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

23.2

53.7

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.3

53.7

212

5521

H01CB02

ATC

octreotide; parenteral

98.5

53.0

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

18.5

52.6

JN7AQ

NOMESCO Finland

Somatostatin receptor SPET med low dose CT

+∞

52.2

A98

ICPC

Health maint/preventive medicine

0.5

52.0

2164

25267

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.2

52.0

526

2657

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

51.8

706

3983

JK3FT

NOMESCO Finland

Exchange of bile duct catheter with radiological guidance

137.3

50.9

ZX090

NOMESCO Finland

Other technic of radiotherapy

81.5

50.0

HAC20

NOMESCO Finland

Total mastectomy

93.3

50.0

R93.3

ICD-10 Finland

Abnormal findings on diagnostic imaging of other parts of digestive tract

12.9

48.6

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

485.2

48.5

8000/3-C25.1

ICD-O-3

Neoplasm, malignant of body of pancreas

+∞

48.0

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

47.0

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

165.9

47.0

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

464.5

46.4

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

3.5

46.3

163

480

WF003

NOMESCO Finland

Adjuvant radiotherapy

238.5

46.1

XX7JT

NOMESCO Finland

Somatostatin isotope ablative therapy

+∞

45.9

Z31.5

ICD-10 Finland

Genetic counselling

4.4

45.8

117

274

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.8

45.6

246

931

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

10.1

45.2

JDH35

NOMESCO Finland

Endoscopic insertion of duodenal stent

+∞

44.9

L01XE03

ATC

[U] erlotinib

+∞

44.9

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

43.8

JLD12

NOMESCO Finland

Endoscopic drainage of pancreatic pseudocyst

119.3

43.8

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

3.8

43.6

134

360

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

43.3

665

3879

L02BA01

ATC

tamoxifen; oral

70.9

43.1

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

42.8

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

9.6

42.5

JDE01

NOMESCO Finland

Laparoscopic gastroenterostomy

+∞

41.8

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

412.9

41.2

R11

ICD-10 Finland

Nausea and vomiting

2.4

41.0

308

1366

N05BA06

ATC

lorazepam; systemic, sublingual

2.7

40.7

231

896

KCD02

NOMESCO Finland

Transurethral resection of bladder

10.4

40.5

JMA11

NOMESCO Finland

Laparoscopic total splenectomy

76.2

40.0

TJA10

NOMESCO Finland

Laparocentesis

89.3

39.9

A41.8

ICD-10 Finland

Other specified sepsis

4.1

39.8

111

278

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

39.7

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

39.7

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.4

38.7

232

1570A

ICD-9 Finland

Malignant neoplasm of pancreas, Head of pancreas

+∞

38.6

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

382.0

38.1

Y77

ICPC

Malignant neoplasm prostate

103.9

37.8

E34.0

ICD-10 Finland

Carcinoid syndrome

135.0

37.8

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.3

37.3

143

445

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

371.7

37.1

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

101.3

36.8

C10AA07

ATC

rosuvastatin; oral

0.5

36.7

483

8080

158

Kela drug reimbursment

Everolimus

+∞

36.5

L02BB03

ATC

bicalutamide; oral

+∞

36.5

JFA65

NOMESCO Finland

Endoscopic insertion of ileum stent

361.4

36.0

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

128.2

35.8

P20

ICPC

Memory disturbance

0.4

35.5

189

4402

197

Kela drug reimbursment

Sunitinib

+∞

35.5

JN1AD

NOMESCO Finland

CT examination of upper part of abdomen

9.6

35.1

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.8

35.1

112

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

35.0

1512

11560

M79.6

ICD-10 Finland

Pain in limb

0.6

35.0

620

9546

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

182.0

34.8

R4110, ,

SPAT

0.3

34.7

2742

EB1VA, ,

NOMESCO Finland

0.3

34.5

2992

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

34.4

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

34.4

I81

ICD-10 Finland

Portal vein thrombosis

10.7

34.0

WX002

NOMESCO Finland

Sedation and analgesia

1.8

33.8

619

3782

ZX070

NOMESCO Finland

Intensity modified radiotherapy

176.9

33.8

WVA20

NOMESCO Finland

Medicine administration

3.7

33.8

109

303

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

33.4

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

64.1

33.1

JLA00

NOMESCO Finland

Exploration of pancreas

330.5

32.9

N06DX01

ATC

memantine; oral

0.3

32.9

2588

N05AD01

ATC

haloperidol; systemic

2.9

32.9

156

550

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

54.9

32.3

C50.99

ICD-10 Finland

Breast, unspecified

320.3

31.9

D44.8

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement

88.5

31.8

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

31.3

8000/3-C25.2

ICD-O-3

Neoplasm, malignant of tail of pancreas

+∞

30.3

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

+∞

30.3

K86.3

ICD-10 Finland

Pseudocyst of pancreas

8.4

30.0

A10BA02

ATC

metformin; oral

1.6

29.7

1067

7731

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

4.8

29.2

140

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

+∞

29.2

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

104.4

28.7

J01MA02

ATC

ciprofloxacin; systemic

1.5

28.7

1208

9053

WX892

NOMESCO Finland

Monitored bed care

2.2

28.6

271

1320

340

Kela drug reimbursment

Everolimus

+∞

28.2

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

28.2

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

+∞

28.2

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

28.2

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

28.2

K31.5

ICD-10 Finland

Obstruction of duodenum

31.2

28.1

JKA20

NOMESCO Finland

Cholecystectomy

3.1

28.0

122

410

JLW98

NOMESCO Finland

Other transluminal endoscopic operation on pancreas

27.5

28.0

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.8

27.8

223

WPA45

NOMESCO Finland

Continuous drug infusion in palliative care

30.3

27.2

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

27.1

378

2113

C10AX09

ATC

ezetimibe; oral

0.4

26.9

193

4034

JKD20

NOMESCO Finland

Anastomosis of bile duct to jejunum

273.4

26.8

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

8.6

26.6

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.6

26.6

497

7679

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

26.1

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

26.1

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.3

26.0

2067

WPA16

NOMESCO Finland

Extensive demanding palliative symptom assessment and treatment

136.1

25.6

A10AE05

ATC

insulin detemir; parenteral

2.3

25.5

206

940

Z76.0

ICD-10 Finland

Issue of repeat prescription

0.5

25.1

280

5031

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

25.0

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

25.0

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

25.0

936

6788

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.9

24.8

117

411

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

70.5

24.8

EB4VA, ,

NOMESCO Finland

0.3

24.7

2205

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

252.1

24.7

Z02.4

ICD-10 Finland

Examination for driving licence

0.6

24.5

508

7681

T90

ICPC

Diabetes non-insulin dependent

1.6

24.5

863

6170

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

5.1

24.5

101

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

3.8

24.5

197

B03XA02

ATC

darbepoetin alfa; parenteral

3.8

24.4

202

NK6AN

NOMESCO Finland

Total body bone isotope imaging

20.2

24.3

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.8

24.2

123

450

ZZR00

NOMESCO Finland

Flap of skin

7.1

24.2

HA1AA

NOMESCO Finland

X-ray mammography

3.0

24.1

106

358

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

24.0

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

24.0

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

24.0

8249/3-C25.2

ICD-O-3

Neuroendocrine tumor, grade 2 of tail of pancreas

+∞

24.0

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.0

23.9

169

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

0.6

23.8

752

10331

JLA10

NOMESCO Finland

Biopsy of pancreas

68.0

23.8

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.7

23.6

127

479

WZC00, ,

SPAT

0.4

23.6

114

2811

T89

ICPC

Diabetes insulin dependent

2.7

23.6

128

485

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

23.5

381

2228

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

5.0

23.2

102

L15

ICPC

Knee symptom/complaint

0.5

23.2

312

5313

JN6AD

NOMESCO Finland

CT of torso and neck

6.3

23.2

M25.5

ICD-10 Finland

Pain in joint

0.6

23.0

391

6237

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

22.9

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

22.9

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

22.9

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

22.9

K86.2

ICD-10 Finland

Cyst of pancreas

4.5

22.9

127

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.1

22.8

235

1180

TJA40

NOMESCO Finland

Percutaneous local drainage of peritoneal cavity

231.6

22.6

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

8.2

22.6

KA1FN

NOMESCO Finland

Isotope renography

8.2

22.6

JLB28

NOMESCO Finland

Endoscopic internal drainage of pancreatic duct

26.1

22.6

I50.9

ICD-10 Finland

Heart failure, unspecified

0.5

22.5

265

4703

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

4.0

22.5

163

K56.7

ICD-10 Finland

Ileus, unspecified

3.5

22.3

215

J94.8

ICD-10 Finland

Other specified pleural conditions

3.7

22.2

192

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

8.0

22.1

WZC15, ,

NOMESCO Finland

35.3

22.0

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.6

22.0

433

6662

YJ1CD

NOMESCO Finland

Very extensive CT examination of abdomen for dose design of radiotherapy

+∞

21.9

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

21.9

C10AA05

ATC

atorvastatin; oral

0.7

21.8

915

11929

E14.8

ICD-10 Finland

Unspecified diabetes mellitus, with unspecified complications

7.2

21.6

JLC00

NOMESCO Finland

Excision of lesion of pancreas

221.5

21.6

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

115.8

21.6

T73

ICPC

Neoplasm endocrine other/unspecified

115.8

21.6

N06DA02

ATC

donepezil; oral

0.3

21.4

1945

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.4

21.3

144

607

322

Kela drug reimbursment

Sunitinib

+∞

20.9

L01CB01

ATC

etoposide; systemic

+∞

20.9

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

20.9

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

20.9

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

20.9

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

24.4

20.8

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

3.0

20.8

302

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

0.6

20.7

551

7916

D77

ICPC

Malignant digestive neopl other/NOS

110.8

20.6

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

110.8

20.6

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.6

20.6

120

472

L13

ICPC

Hip symptom/complaint

0.5

20.5

244

4329

SAA01

NOMESCO Finland

Simple examination of mouth

0.7

20.4

1247

15243

TPX15

NOMESCO Finland

Removal of vascular injection port

20.2

20.4

JFC00

NOMESCO Finland

Entero-enterostomy

48.3

20.2

N05CF01

ATC

zopiclone; oral

1.5

20.1

984

7468

R4110

NOMESCO Finland

Physiotherapy

1.5

19.9

740

5312

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.7

19.8

100

C25.3

ICD-10 Finland

Malignant neoplasm: Pancreatic duct

+∞

19.8

C24.1

ICD-10 Finland

Malignant neoplasm: Ampulla of Vater

+∞

19.8

C24.9

ICD-10 Finland

Malignant neoplasm: Biliary tract, unspecified

+∞

19.8

ZX080

NOMESCO Finland

Image guided radiotherapy

+∞

19.8

SAA02

NOMESCO Finland

Basic examination of mouth

0.7

19.6

1070

13384

GD1AD

NOMESCO Finland

Thorax CT examination

2.1

19.6

181

871

C50

ICD-10 Finland

Malignant neoplasm of breast

105.7

19.6

A41.9

ICD-10 Finland

Sepsis, unspecified

2.4

19.2

140

611

SPAT1053

SPAT

Memory test

0.5

19.2

234

4130

SPAT1262

SPAT

Handing over of treatment supplies

1.6

19.0

563

3841

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

3.8

19.0

151

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.6

19.0

115

461

L01XE10

ATC

[U] everolimus

+∞

18.8

8246/3-C25.9

ICD-O-3

Neuroendocrine carcinoma, NOS, of pancreas, NOS

+∞

18.8

OAA41

NOMESCO Finland

Health check based on individual needs

+∞

18.8

325

Kela drug reimbursment

Erlotinib

+∞

18.8

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

18.8

L01EG02

ATC

everolimus; oral

+∞

18.8

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

7.7

18.7

L03

ICPC

Low back symptom/complaint

0.6

18.6

373

5755

E89.1

ICD-10 Finland

Postprocedural hypoinsulinaemia

100.7

18.6

L02BG03

ATC

anastrozole; oral

191.1

18.5

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.3

18.5

207

Z01.2

ICD-10 Finland

Dental examination

0.7

18.3

632

8645

SPAT1290

SPAT

Preparation of deceased person

25.2

18.2

ZXE00

NOMESCO Finland

One hour or less

1.4

18.1

980

7550

SDA03

NOMESCO Finland

Periodontal treatment

0.6

18.0

514

7320

H25.1

ICD-10 Finland

Senile nuclear cataract

0.7

17.8

638

8673

L01EX01

ATC

sunitinib; oral

+∞

17.7

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

+∞

17.7

PHC71

NOMESCO Finland

Suture of mesenteric or portal vein

+∞

17.7

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

17.7

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

17.7

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

20.2

17.7

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

20.2

17.7

V03AF03

ATC

calcium folinate; systemic

181.0

17.5

ZX112

NOMESCO Finland

Subcutaneous

5.3

17.5

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

0.6

17.4

294

4748

D70.89

ICD-10 Finland

Neutropenic splenomegaly

5.5

17.4

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

5.4

17.3

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.4

17.3

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

0.7

17.2

808

10460

L08

ICPC

Shoulder symptom/complaint

0.6

17.0

303

4825

D13

ICPC

Jaundice

25.7

16.9

C10AC01

ATC

colestyramine; oral

2.8

16.9

316

UJK12

NOMESCO Finland

Peroral cholangioscopy

14.1

16.8

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

16.7

1579X

ICD-9 Finland

Malignant neoplasm of pancreas, Pancreas, part unspecified

+∞

16.7

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

+∞

16.7

8500/3-C25.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of tail of pancreas

+∞

16.7

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

16.7

8500/3-C25.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of body of pancreas

+∞

16.7

WZC30, ,

SPAT

0.3

16.7

1703

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

4.0

16.7

115

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

0.7

16.6

618

8369

JN4SR

NOMESCO Finland

Very extensive PET-CT of receptors in whole body

90.6

16.6

WX600

NOMESCO Finland

Single shot through catheter

6.0

16.5

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

170.9

16.5

SFA10

NOMESCO Finland

One-surface restoration

0.7

16.1

868

11014

N02AA03

ATC

hydromorphone; systemic, rectal

30.2

16.1

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.3

16.0

190

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

0.5

15.8

130

2619

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

12.3

15.8

N05AX08

ATC

risperidone; systemic

0.4

15.8

2176

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

5.0

15.7

C17.0

ICD-10 Finland

Malignant neoplasm: Duodenum

+∞

15.6

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

15.6

L01XE04

ATC

[U] sunitinib

+∞

15.6

C90.0

ICD-10 Finland

Multiple myeloma

+∞

15.6

8240/3-C25.2

ICD-O-3

Neuroendocrine tumor, NOS, of tail of pancreas

+∞

15.6

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

15.6

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

15.6

SDA02

NOMESCO Finland

Periodontal treatment, brief

0.7

15.6

465

6599

X76

ICPC

Malignant neoplasm breast female

85.5

15.6

XF612

NOMESCO Finland

Measurement of central venous pressure

22.1

15.5

K85

ICD-10 Finland

Acute pancreatitis

2.9

15.1

250

WPA41

NOMESCO Finland

Psychosocial conversational support in palliative care

45.2

15.1

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

6.3

15.0

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

14.0

15.0

R01AD58

ATC

fluticasone, combinations; nasal

0.6

15.0

202

3481

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

0.6

15.0

265

4244

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

0.6

15.0

331

5020

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

14.9

984

7786

K85.0

ICD-10 Finland

Idiopathic acute pancreatitis

4.7

14.9

WGA11

NOMESCO Finland

Planning of pain management

6.5

14.9

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.6

14.9

322

4909

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

56.9

14.8

E16.10

ICD-10 Finland

Hyperinsulinism

56.9

14.8

WPA44

NOMESCO Finland

Nursing home for palliative care

16.5

14.7

DAX08

NOMESCO Finland

Fitting of hearing aid

0.3

14.7

1387

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

3.9

14.7

108

WPA43, ,

SPAT

21.1

14.6

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

14.6

PHN72

NOMESCO Finland

Plastic repair of superior mesenteric or portal vein

+∞

14.6

8249/3-C25.1

ICD-O-3

Neuroendocrine tumor, grade 2 of body of pancreas

+∞

14.6

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

14.6

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

14.6

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

14.6

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

14.6

SPAT1255

SPAT

Intravenous administration of medicine

1.8

14.5

212

1197

E13

ICD-10 Finland

Other specified diabetes mellitus

10.9

14.5

JN4DD

NOMESCO Finland

Scout CT scan of torso

150.7

14.5

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

150.7

14.5

TDA90, ,

SPAT

0.3

14.5

1433

JLB12

NOMESCO Finland

Transduodenal endoscopic incision of pancreatic duct orifice

36.2

14.4

N06DA03

ATC

rivastigmine; oral, transdermal

0.3

14.4

1326

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

3.9

14.4

105

L17

ICPC

Foot/toe symptom/complaint

0.7

14.2

490

6773

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

4.0

14.1

102

WX100

NOMESCO Finland

Conjunctival surface anesthesia

0.6

14.1

188

3250

I50.0

ICD-10 Finland

Congestive heart failure

0.5

14.0

121

2396

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

6.0

13.9

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

13.7

444

3073

D19

ICPC

Teeth/gum symptom/complaint

0.6

13.7

351

5164

K02.1

ICD-10 Finland

Caries of dentine

0.7

13.7

942

11587

WX320

NOMESCO Finland

Spinalanesthesy

0.6

13.6

366

5324

SDA04

NOMESCO Finland

Demanding periodontal treatment

0.6

13.6

323

4828

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

+∞

13.5

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

13.5

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

13.5

L01EB02

ATC

erlotinib; oral

+∞

13.5

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

13.5

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

13.5

8480/3-C25.9

ICD-O-3

Mucinous adenocarcinoma of pancreas, NOS

+∞

13.5

8010/3-C25.0

ICD-O-3

Carcinoma, NOS, of head of pancreas

+∞

13.5

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

13.5

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

0.6

13.5

210

3487

G04BD12

ATC

mirabegron; oral

0.5

13.5

139

2603

R93.2

ICD-10 Finland

Abnormal findings on diagnostic imaging of liver and biliary tract

4.5

13.5

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

0.7

13.5

578

7687

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

140.6

13.5

JN7AN

NOMESCO Finland

Somatostatin receptor isotope imaging

140.6

13.5

JKD00

NOMESCO Finland

Anastomosis of gallbladder to jejunum

140.6

13.5

SPAT1088

SPAT

Blood transfusion

6.1

13.4

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

0.3

13.3

1229

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

0.5

13.3

157

2816

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.3

13.0

436

WPA13, ,

SPAT

19.1

12.9

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

0.5

12.8

123

2357

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

50.2

12.8

GD1AA, ,

SPAT

0.5

12.8

106

2132

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

5.4

12.8

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.7

12.7

392

5554

R83

ICPC

Respiratory infection other

0.6

12.7

185

3125

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

70.2

12.6

ZYC01, ,

SPAT

0.4

12.5

1757

L02BX02

ATC

degarelix; parenteral

+∞

12.5

YX9AW, ,

NOMESCO Finland

+∞

12.5

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

12.5

8140/3-C24.1

ICD-O-3

Adenocarcinoma, NOS, of ampulla of Vater

+∞

12.5

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

12.5

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

12.5

1571A

ICD-9 Finland

Malignant neoplasm of pancreas, Body of pancreas

+∞

12.5

JJB10

NOMESCO Finland

Atypcal resection of liver

+∞

12.5

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

12.5

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

12.5

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

12.5

ZX050

NOMESCO Finland

Stereotactic radiotherapy

24.4

12.5

R03AC02

ATC

salbutamol; inhalant

0.7

12.4

1007

12149

OAB44, ,

SPAT

0.4

12.4

1530

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

0.7

12.4

483

6551

R1250, ,

SPAT

0.1

12.3

471

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

14.4

12.3

ZXD05

NOMESCO Finland

Urgent procedure

1.4

12.2

793

6222

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

2.8

12.2

206

ZXF10

NOMESCO Finland

Interruption caused by technical failure of equipment

37.7

12.2

SPAT1110

SPAT

Measurement of pain intensity

4.3

12.2

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

3.0

12.2

174

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

12.2

252

1571

WPA11

NOMESCO Finland

Developing a plan for palliative care

12.4

12.1

L12

ICPC

Hand/finger symptom/complaint

0.6

12.1

187

3111

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.5

12.0

306

N07BC02

ATC

methadone; systemic

11.1

12.0

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

5.2

12.0

EBA00

NOMESCO Finland

Extraction of tooth

0.7

11.9

562

7381

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

4.5

11.9

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

46.8

11.9

WX882

NOMESCO Finland

High dependency care

2.4

11.7

353

AXX01, ,

SPAT

0.3

11.7

951

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

5.5

11.6

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

30.1

11.6

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

65.2

11.6

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

3.6

11.6

103

B01AC04

ATC

clopidogrel; oral

0.7

11.6

330

4762

DFF00

NOMESCO Finland

Pure tone audiometry

0.5

11.5

114

2162

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

0.3

11.5

988

A97

ICPC

No disease

0.6

11.5

259

3931

FM1FN

NOMESCO Finland

Heart function isotope examination

+∞

11.5

XW2BT

NOMESCO Finland

Other cytological test with X-ray guidance

+∞

11.5

L01BC04

ATC

carmofur; oral

+∞

11.5

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

11.5

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

11.5

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

11.5

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

11.5

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

11.5

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

120.4

11.4

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

120.4

11.4

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

120.4

11.4

C76.2

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Abdomen

120.4

11.4

JDA12

NOMESCO Finland

Endoscopic insertion of gastric stent

120.4

11.4

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.5

11.4

114

Z96.1

ICD-10 Finland

Presence of intraocular lens

0.6

11.4

256

3888

SDA01

NOMESCO Finland

Periodontal treatment, very brief

0.7

11.4

329

4735

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

3.2

11.4

134

207

Kela drug reimbursment

Chronic arrhythmias

0.7

11.4

318

4608

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.7

11.3

551

7212

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

4.1

11.3

H02

ICPC

Hearing complaint

0.6

11.3

233

3613

ZXC96

NOMESCO Finland

Robot assisted procedure

5.1

11.3

WX704

NOMESCO Finland

Intubation

1.7

11.2

186

1091

F03

ICD-10 Finland

Unspecified dementia

0.4

11.2

1384

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.0

11.2

126

654

D01

ICPC

Abdominal pain/cramps general

1.6

11.2

276

1796

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.4

11.2

1283

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

17.1

11.2

I10

ICD-10 Finland

Essential (primary) hypertension

0.8

11.1

1642

18408

OAB42, ,

SPAT

0.5

11.1

137

2430

K03.64

ICD-10 Finland

Dental calculus supragingival

0.7

11.0

363

5097

NG1AA, ,

SPAT

0.3

11.0

933

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

10.1

11.0

Z2446

NOMESCO Finland

Social worker

1.9

11.0

143

780

JFB30

NOMESCO Finland

Right hemicolectomy

4.8

10.9

H81

ICPC

Excessive ear wax

0.7

10.9

292

4276

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

0.3

10.8

1105

B01AF02

ATC

apixaban; oral

0.6

10.8

229

3528

I50.1

ICD-10 Finland

Left ventricular failure

0.4

10.7

1400

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.8

10.7

162

926

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

21.5

10.7

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.1

10.5

462

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.5

10.5

330

2265

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.9

10.5

133

719

Z3231

NOMESCO Finland

Registered nurse

1.4

10.5

671

5235

R96

ICPC

Asthma

0.5

10.5

1869

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

10.1

10.5

K75.0

ICD-10 Finland

Abscess of liver

9.2

10.5

Z51.0

ICD-10 Finland

Radiotherapy session

110.4

10.4

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

110.4

10.4

JDK01, ,

NOMESCO Finland

110.4

10.4

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

110.4

10.4

8000/3-C25.8

ICD-O-3

Neoplasm, malignant of overlapping lesion of pancreas

+∞

10.4

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

10.4

9680/3-C25.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of pancreas, NOS

+∞

10.4

8249/3-C25.0

ICD-O-3

Neuroendocrine tumor, grade 2 of head of pancreas

+∞

10.4

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

10.4

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

10.4

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

10.4

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

10.4

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

10.4

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

10.4

WD215

NOMESCO Finland

Multiple therapy of methastized malignancy with hormones

+∞

10.4

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

10.4

Z01.7

ICD-10 Finland

Laboratory examination

0.6

10.4

198

3130

H25.8

ICD-10 Finland

Other senile cataract

0.6

10.3

195

3091

A21

ICPC

Risk factor for malignancy

32.6

10.3

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

0.5

10.3

126

2241

Z53.8

ICD-10 Finland

Procedure not carried out for other reasons

4.9

10.3

XX9TB

NOMESCO Finland

Complementary X-ray examination with contrast

18.8

10.3

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

4.6

10.2

D13.9

ICD-10 Finland

Benign neoplasm: Ill-defined sites within the digestive system

23.4

10.2

F51.0

ICD-10 Finland

Nonorganic insomnia

0.5

10.2

127

2248

BBA70

NOMESCO Finland

Implantation or transplantation of parathyroid gland

13.1

10.1

N05BA04

ATC

oxazepam; oral

1.3

10.1

704

5561

ZY010

NOMESCO Finland

Hospital outpatient

2.1

10.1

416

R74

ICPC

Upper respiratory infection acute

0.7

10.1

312

4441

2390A

ICD-9 Finland

Neoplasm of unspecified nature, Digestive system

7.9

10.1

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

0.5

10.1

102

1922

L01

ICPC

Neck symptom/complaint

0.6

10.1

172

2795

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

8.4

10.0

TQW20

NOMESCO Finland

Tatoe

40.2

10.0

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.0

10.0

102

513

D82

ICPC

Teeth/gum disease

0.7

10.0

493

6455

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.4

9.9

266

M70.6

ICD-10 Finland

Trochanteric bursitis

0.6

9.9

159

2626

Z3226

NOMESCO Finland

Physiotherapist

1.4

9.9

443

3256

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

3.0

9.8

141

WPA44, ,

SPAT

8.7

9.8

JFB00

NOMESCO Finland

Partial resection of small intestine

3.0

9.8

147

OAB43, ,

SPAT

0.5

9.8

118

2106

R05

ICPC

Cough

0.7

9.7

352

4868

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

9.7

211

1331

S77

ICPC

Malignant neoplasm of skin

13.4

9.7

D44.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Endocrine gland, unspecified

55.2

9.6

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

2.6

9.6

211

OAA67, ,

SPAT

0.4

9.5

1335

D75

ICPC

Malignant neoplasm colon/rectum

15.1

9.5

I48.2

ICD-10 Finland

Chronic atrial fibrillation

0.4

9.5

1095

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

7.1

9.5

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

0.6

9.5

166

2681

AA1AD

NOMESCO Finland

CT of head and brain

0.7

9.4

606

7636

JJ2CT

NOMESCO Finland

Biopsy of liver with CT guidance

100.3

9.4

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

100.3

9.4

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

0.8

9.4

935

11108

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

9.4

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

9.4

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

+∞

9.4

PHH32

NOMESCO Finland

Plastic repair of superior mesenteric or portal vein

+∞

9.4

6706

FHL

Pancreatic homeectomy (eg Whipple)

+∞

9.4

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

9.4

L02BX03

ATC

abiraterone; oral

+∞

9.4

1572A

ICD-9 Finland

Malignant neoplasm of pancreas, Tail of pancreas

+∞

9.4

C24.02

ICD-10 Finland

Common bile duct

+∞

9.4

9061/3-C62.9

ICD-O-3

Seminoma, NOS, of testis, NOS

+∞

9.4

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

9.4

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

0.7

9.4

472

6171

M54.4

ICD-10 Finland

Lumbago with sciatica

0.6

9.3

213

3234

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

21.7

9.3

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.0

9.3

SFA20

NOMESCO Finland

Two-surface restoration

0.8

9.3

974

11500

K02.0

ICD-10 Finland

Caries limited to enamel

0.6

9.3

152

2496

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

0.2

9.2

576

SPAT1111

SPAT

Planning of analgesia

3.0

9.2

136

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

0.5

9.2

1382

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

9.2

1221

10490

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

0.7

9.1

431

5697

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

0.6

9.1

205

3120

C09CA06

ATC

candesartan; oral

0.7

9.0

379

5111

P06

ICPC

Sleep disturbance

0.5

9.0

108

1934

201

Kela drug reimbursment

Chronic cardiac insufficiency

0.5

9.0

1664

TKE10

NOMESCO Finland

Puncture of prostate

36.8

9.0

R02

ICPC

Shortness of breath/dyspnoea

0.6

9.0

193

2971

M54.5

ICD-10 Finland

Low back pain

0.7

9.0

575

7257

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.1

9.0

389

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

0.5

9.0

1504

G04CA52

ATC

tamsulosin and dutasteride; systemic

0.6

9.0

180

2813

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

0.2

8.9

661

WPA43

NOMESCO Finland

A doctor's home visit to perform palliative care

18.6

8.9

RD210, ,

NOMESCO Finland

3.0

8.9

133

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.0

8.8

466

L90

ICPC

Osteoarthrosis of knee

0.5

8.8

1417

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.4

8.8

1186

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

0.8

8.8

742

9025

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

0.6

8.8

130

2194

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

10.7

8.8

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

8.7

857

7080

R42

ICD-10 Finland

Dizziness and giddiness

0.7

8.7

433

5681

OAB48, ,

SPAT

0.4

8.7

1247

SFA30

NOMESCO Finland

Three-surface restoration

0.8

8.7

694

8502

R17.0

ICD-10 Finland

Hyperbilirubinaemia with mention of jaundice, not elsewhere classified

50.1

8.7

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

50.1

8.7

L30.9

ICD-10 Finland

Dermatitis, unspecified

0.7

8.6

256

3682

N03AX16

ATC

[U] pregabalin

1.3

8.6

572

4474

H26.4

ICD-10 Finland

After-cataract

0.6

8.6

166

2619

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

0.8

8.6

680

8343

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

4.6

8.6

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

0.5

8.6

1676

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

0.7

8.6

509

6500

HAE99

NOMESCO Finland

Other reconstruction of breast

16.3

8.5

R05

ICD-10 Finland

Cough

0.7

8.5

310

4290

A10AC01

ATC

insulin (human); parenteral

1.5

8.5

249

1685

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

20.1

8.5

C01DA14

ATC

isosorbide mononitrate; oral

0.7

8.4

412

5425

G47.3

ICD-10 Finland

Sleep apnoea

0.7

8.4

336

4575

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

90.3

8.4

WPA12

NOMESCO Finland

A meeting to support loved ones after the patient's death

90.3

8.4

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

90.3

8.4

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

90.3

8.4

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

90.3

8.4

SPAT1269

SPAT

Other puncture and/or drainage

4.3

8.4

K92.0

ICD-10 Finland

Haematemesis

2.1

8.4

400

KAD00

NOMESCO Finland

Partial nephrectomy

12.8

8.4

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

+∞

8.3

WF090

NOMESCO Finland

Profylactic radiotherapy

+∞

8.3

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

8.3

L02AE04

ATC

triptorelin; parenteral

+∞

8.3

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

8.3

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

+∞

8.3

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

8.3

JN7SN

NOMESCO Finland

Somatostatin receptor SPECT

+∞

8.3

L02BB04

ATC

enzalutamide; oral

+∞

8.3

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

8.3

1BC05, ,

NOMESCO Finland

+∞

8.3

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

8.3

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

8.3

KCC10

NOMESCO Finland

Cystoprostatectomy

+∞

8.3

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

8.3

JLA20

NOMESCO Finland

Needle biopsy of pancreas

+∞

8.3

8720/3-C44.6

ICD-O-3

Malignant melanoma, NOS, of skin of upper limb and shoulder

+∞

8.3

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

+∞

8.3

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

8.3

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

+∞

8.3

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

8.3

UJD02

NOMESCO Finland

Gastroscopy

1.7

8.3

140

828

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

8.3

122

694

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

0.6

8.2

119

2021

A10AE06

ATC

insulin degludec; parenteral

2.0

8.2

465

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

14.5

8.2

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

7.5

8.1

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

0.6

8.1

121

2039

JKE12

NOMESCO Finland

Endoscopic extraction of calculus from bile duct

2.5

8.1

204

SPAT1122

SPAT

Ascites puncture

33.4

8.1

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

8.1

D48.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Retroperitoneum

17.2

8.1

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

11.7

8.1

L02AE03

ATC

goserelin; implant

8.9

8.0

JJA20

NOMESCO Finland

Open biopsy of liver

10.0

8.0

JN5KR

NOMESCO Finland

Very extensive PET-CT of upper body metabolism (eyebrows to thighs)

22.1

8.0

M01AH05

ATC

etoricoxib; oral

0.8

8.0

1169

13354

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.9

8.0

534

D02

ICPC

Abdominal pain epigastric

1.7

7.9

144

870

K31.0

ICD-10 Finland

Acute dilatation of stomach

13.0

7.9

H04.10

ICD-10 Finland

Dry eye syndrome

0.6

7.9

116

1958

P70

ICPC

Dementia

0.3

7.8

657

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.0

7.8

431

250, ,

Kela drug reimbursment

0.2

7.8

384

XX9CW

NOMESCO Finland

Submitting image material and/or investigation material to patient

3.8

7.8

R06AX27

ATC

desloratadine; oral

0.7

7.8

324

4384

R01AD59

ATC

mometasone, combinations; nasal

0.3

7.8

622

DFF15

NOMESCO Finland

Speech audiometry

0.4

7.7

1016

A02BC05

ATC

esomeprazole; systemic

1.3

7.7

1043

8929

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

45.1

7.7

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

45.1

7.7

K52.1

ICD-10 Finland

Toxic gastroenteritis and colitis

45.1

7.7

Z71.8

ICD-10 Finland

Other specified counselling

0.8

7.7

502

6339

N05AH04

ATC

quetiapine; oral

0.7

7.7

215

3130

BBA50

NOMESCO Finland

Total parathyroidectomy

18.4

7.6

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

18.4

7.6

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

18.4

7.6

L28

ICPC

Limited function/disability (L)

0.7

7.6

377

4956

A06AH05

ATC

naldemedine; oral

25.1

7.6

H25.0

ICD-10 Finland

Senile incipient cataract

0.5

7.6

1485

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.1

7.6

334

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.4

7.5

218

R053, ,

ICD-10 Finland

0.2

7.5

375

E87.6

ICD-10 Finland

Hypokalaemia

1.8

7.5

102

566

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

0.5

7.5

1247

J45.9

ICD-10 Finland

Asthma, unspecified

0.7

7.5

286

3930

SCA01

NOMESCO Finland

Preventive oral health care, short

0.7

7.5

336

4493

N17

ICPC

Vertigo/dizziness

0.7

7.5

191

2834

K26.0

ICD-10 Finland

Duodenal ulcer, acute with haemorrhage

2.8

7.5

130

NF1AA, ,

SPAT

0.2

7.5

544

WX290

NOMESCO Finland

Other blockage of nerve

0.8

7.4

628

7669

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

2.7

7.4

136

6672

FHL

Cholecocenterostomy

80.3

7.4

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

80.3

7.4

KFC10

NOMESCO Finland

Bilateral orchiectomy

80.3

7.4

XJA00

NOMESCO Finland

Intraoperative abdominal ultrasonography

80.3

7.4

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

80.3

7.4

JFB40

NOMESCO Finland

Resection of transverse colon

80.3

7.4

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

3.5

7.4

W19

ICD-10 Finland

Unspecified fall

0.6

7.4

124

2025

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.6

7.3

166

TQW99

NOMESCO Finland

Other minor procedure on skin

1.9

7.3

513

WX725

NOMESCO Finland

Noninvasive ventilation

1.7

7.3

122

720

R10.0

ICD-10 Finland

Acute abdomen

2.0

7.3

407

WE100

NOMESCO Finland

Profylactic cytostatic therapy

+∞

7.3

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

+∞

7.3

C62.11

ICD-10 Finland

Malignant tumor of the descending testicle, seminoma

+∞

7.3

C85.0

ICD-10 Finland

Lymphosarcoma

+∞

7.3

WGA10

NOMESCO Finland

Measurement of pain intensity

+∞

7.3

Z515, C250,

ICD-10 Finland

+∞

7.3

1733A

ICD-9 Finland

Other malignant neoplasm of skin, Skin of other and unspecified parts of face[KASVOJEN IHON SYÖPÄ,CA BASOCELLULARE]

+∞

7.3

PC2SC

NOMESCO Finland

Liver angiography with X-ray

+∞

7.3

1CD02, ,

NOMESCO Finland

+∞

7.3

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

7.3

JL1CT

NOMESCO Finland

Biopsy of pancreas with CT guidance

+∞

7.3

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

7.3

8240/3-C25.0

ICD-O-3

Neuroendocrine tumor, NOS, of head of pancreas

+∞

7.3

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

7.3

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

7.3

18699

ICD-8 Finland

Malignant neoplasm of testis

+∞

7.3

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

7.3

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

7.3

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

+∞

7.3

C24.0

ICD-10 Finland

Malignant neoplasm: Extrahepatic bile duct

+∞

7.3

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

7.3

8550/3-C25.9

ICD-O-3

Acinar cell carcinoma of pancreas, NOS

+∞

7.3

YJ3VG

NOMESCO Finland

MRI examination of abdomen with high intesity magnet for dose design of radiotherapy

+∞

7.3

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

7.3

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

7.3

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

7.3

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

+∞

7.3

V03AH01

ATC

diazoxide; systemic

+∞

7.3

L03AB05

ATC

interferon alfa-2b; parenteral

+∞

7.3

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

+∞

7.3

HAC25

NOMESCO Finland

Radical mastectomy

+∞

7.3

JK1AT

NOMESCO Finland

Cathetrisation of bile cyst with radiological guidance

10.9

7.3

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

0.7

7.3

349

4618

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

0.2

7.2

365

Z97.4

ICD-10 Finland

Presence of external hearing-aid

0.5

7.2

1149

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.5

7.2

174

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

0.6

7.2

172

2584

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

30.1

7.1

BCA30

NOMESCO Finland

Unilateral adrenalectomy

30.1

7.1

WPA15, ,

SPAT

20.1

7.1

WZB00, ,

SPAT

0.5

7.1

1184

T93

ICPC

Lipid disorder

0.5

7.1

1444

G30.8

ICD-10 Finland

Other Alzheimer disease

0.3

7.1

696

F06.7

ICD-10 Finland

Mild cognitive disorder

0.3

7.1

696

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

5.6

7.1

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.3

7.0

469

3665

G03HA01

ATC

cyproterone; systemic

10.0

7.0

I25.2

ICD-10 Finland

Old myocardial infarction

0.6

7.0

125

2011

M19.0

ICD-10 Finland

Primary arthrosis of other joints

0.6

7.0

123

1986

H43.8

ICD-10 Finland

Other disorders of vitreous body

0.6

7.0

107

1789

HAB99

NOMESCO Finland

Other partial excision of mammary gland

4.2

7.0

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

0.6

7.0

1662

OAA80, ,

SPAT

0.3

7.0

629

N06DA04

ATC

galantamine; oral

0.3

7.0

629

Z2221

NOMESCO Finland

Medical doctor

1.3

6.9

599

4850

I48.1

ICD-10 Finland

Persistent atrial fibrillation

0.4

6.9

984

JFF23

NOMESCO Finland

Transversostomy

5.8

6.9

I48

ICD-10 Finland

Atrial fibrillation and flutter

0.8

6.9

559

6871

F29

ICPC

Eye symptom/complaint other

0.6

6.9

106

1766

L04AX03

ATC

methotrexate; systemic

0.6

6.8

1614

K81.0

ICD-10 Finland

Acute cholecystitis

2.0

6.8

341

RD160, ,

NOMESCO Finland

10.9

6.8

K85

ICPC

Elevated blood pressure

0.7

6.8

293

3945

JCF12

NOMESCO Finland

Endoscopic insertion of prosthetic tube into oesphagus

9.3

6.8

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.8

6.8

497

L16

ICPC

Ankle symptom/complaint

0.6

6.8

126

2005

A07AA09

ATC

vancomycin; oral

2.4

6.8

173

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

2.4

6.8

173

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

40.1

6.8

NB1AA, ,

SPAT

0.2

6.7

478

K65.0

ICD-10 Finland

Acute peritonitis

2.7

6.7

132

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

0.8

6.7

461

5794

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.4

6.7

180

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

0.6

6.7

147

2251

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

22.6

6.7

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

0.4

6.6

746

H13

ICPC

Plugged feeling ear

0.7

6.6

364

4723

R07.4

ICD-10 Finland

Chest pain, unspecified

0.8

6.6

560

6848

N39.4

ICD-10 Finland

Other specified urinary incontinence

0.6

6.6

117

1882

XCH00

NOMESCO Finland

Eye pressure measurement

0.5

6.6

938

JN1CM

NOMESCO Finland

Upper part of abdomen extensive MRI examination with 3 Tesla magnet

12.3

6.6

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

0.6

6.6

121

1930

P01AB01

ATC

metronidazole; oral, rectal

1.2

6.6

910

7783

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

0.6

6.6

105

1734

K86

ICPC

Hypertension uncomplicated

0.7

6.6

233

3244

EBA05

NOMESCO Finland

Complicated extraction of tooth

0.7

6.6

300

4002

N40

ICD-10 Finland

Hyperplasia of prostate

0.8

6.5

531

6532

J01MA14

ATC

moxifloxacin; systemic

1.5

6.5

211

1458

E14

ICD-10 Finland

Unspecified diabetes mellitus

6.2

6.5

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

3.9

6.4

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

0.6

6.4

147

2232

C82.1

ICD-10 Finland

Follicular lymphoma grade II

70.0

6.4

D74

ICPC

Malignant neoplasm stomach

70.0

6.4

JDH32

NOMESCO Finland

Endoscopic dilatation of duodenum

70.0

6.4

M05BA02

ATC

clodronic acid; systemic

70.0

6.4

L02BG06

ATC

exemestane; oral

70.0

6.4

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

70.0

6.4

JKC30

NOMESCO Finland

Partial excision of bile duct and anastomosis to jejunum

70.0

6.4

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

0.5

6.4

983

E13.7

ICD-10 Finland

Other specified diabetes mellitus, with multiple complications

7.4

6.4

N02BF01

ATC

gabapentin; oral

0.6

6.4

110

1784

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

0.6

6.4

148

2241

JLB35

NOMESCO Finland

Transduodenal endoscopic extraction of foreign body from pancreatic duct

14.3

6.4

JA3CT

NOMESCO Finland

Cathetrisation of abdominal cavity with CT guidance

14.3

6.4

R5140

NOMESCO Finland

Monitoring the use of the aid

0.6

6.4

139

2131

H29

ICPC

Ear symptom/complaint other

0.7

6.4

169

2486

T87

ICPC

Hypoglycaemia

4.1

6.3

XX4BW, ,

NOMESCO Finland

11.0

6.3

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

5.5

6.3

C79.6

ICD-10 Finland

Secondary malignant neoplasm of ovary

+∞

6.3

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

6.3

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

6.3

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

+∞

6.3

C01

ICD-10 Finland

Malignant neoplasm of base of tongue

+∞

6.3

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

6.3

C259, 8148, 2

ICD-O-3

+∞

6.3

C78.4

ICD-10 Finland

Secondary malignant neoplasm of small intestine

+∞

6.3

C26.0

ICD-10 Finland

Malignant neoplasm: Intestinal tract, part unspecified

+∞

6.3

C79.0

ICD-10 Finland

Secondary malignant neoplasm of kidney and renal pelvis

+∞

6.3

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

6.3

8140/3-C80.9

ICD-O-3

Adenocarcinoma, NOS, of unknown primary site

+∞

6.3

C50.52

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor

+∞

6.3

C26.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of digestive system

+∞

6.3

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

6.3

8480/3-C25.0

ICD-O-3

Mucinous adenocarcinoma of head of pancreas

+∞

6.3

8150/3-C25.9

ICD-O-3

Pancreatic neuroendocrine tumor, nonfunctioning of pancreas, NOS

+∞

6.3

C24.09

ICD-10 Finland

Biliary duct or passage NOS

+∞

6.3

WB131

NOMESCO Finland

Very demanding neoadjuvant cytostatic therapy

+∞

6.3

8020/3-C25.9

ICD-O-3

Carcinoma, undifferentiated, NOS, of pancreas, NOS

+∞

6.3

1CB02, ,

NOMESCO Finland

+∞

6.3

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

6.3

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

6.3

C23

ICD-10 Finland

Malignant neoplasm of gallbladder

+∞

6.3

8151/3-C25.9

ICD-O-3

Insulinoma, NOS, of pancreas, NOS

+∞

6.3

C21.1

ICD-10 Finland

Malignant neoplasm: Anal canal

+∞

6.3

D63.0

ICD-10 Finland

Anaemia in neoplastic disease

+∞

6.3

C76.8

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Overlapping lesion of other and ill-defined sites

+∞

6.3

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

+∞

6.3

8010/3-C25.2

ICD-O-3

Carcinoma, NOS, of tail of pancreas

+∞

6.3

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

6.3

8246/3-C25.2

ICD-O-3

Neuroendocrine carcinoma, NOS, of tail of pancreas

+∞

6.3

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

6.3

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

+∞

6.3

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

0.7

6.2

175

2547

L82

ICD-10 Finland

Seborrhoeic keratosis

0.7

6.2

263

3556

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

26.7

6.2

JLB42

NOMESCO Finland

Transduodenal endoscopic dilatation of pancreatic duct

26.7

6.2

L03AA04, ,

ATC

26.7

6.2

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

26.7

6.2

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

26.7

6.2

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

0.4

6.2

681

R06.0

ICD-10 Finland

Dyspnoea

0.8

6.2

538

6566

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

0.4

6.1

617

HA1RA, ,

SPAT

0.3

6.1

464

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

0.7

6.1

182

2617

A10BH01

ATC

sitagliptin; oral

1.4

6.1

287

2126

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.8

6.1

537

C01AA05

ATC

digoxin; systemic

0.7

6.0

171

2484

Z01.1

ICD-10 Finland

Examination of ears and hearing

0.7

6.0

220

3048

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1843

8184

4.04

321.89

5.7

2.4

92.14

60.88

u/l

1.46

1772

7507

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

877

301

40.06

307.65

6.2

1.9

6011.76

27.87

u/ml

7.64

818

271

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1840

1391

30.60

307.65

6.1

1.4

64.78

2.78

ug/l

3.30

1735

1047

(3000570) Elastase.pancreatic [Mass/mass] in Stool

948

744

17.83

307.65

1.6

1.4

146.18

283.32

ug/g

43.81

562

469

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1032

2085

6.89

307.65

3.5

1.9

0.18

0.20

g/l

3.71

981

1892

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

391

119

37.40

307.65

1.2

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1153

503

35.68

307.65

6.8

1.8

15523.33

268.54

u/ml

2.05

1053

397

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1071

2545

5.87

307.65

5.2

2.1

40.74

8.08

umol/l

46.10

1008

2212

(4035726) Immunohistochemistry procedure

575

623

11.08

307.65

1.4

1.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

584

108

66.22

307.65

4.8

1.8

15.92

4.56

nmol/l

0.65

577

100

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

790

2191

4.48

261.02

7.4

2.2

106.66

40.66

u/l

0.88

694

1799

(40768441) Liver Pathology biopsy report

180

24.74

252.74

1.0

1.5

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2219

12672

3.57

233.85

23.7

3.9

27.05

12.32

umol/l

35.00

2171

11858

(3023368) Bacteria identified in Blood by Culture

1552

7726

3.00

195.80

6.5

4.0

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

198

264.04

195.17

2.9

4.1

710.17

633.50

u/l

—

180

(3024561) Albumin [Mass/volume] in Serum or Plasma

1992

11647

2.95

181.58

11.6

3.9

31.06

35.24

g/l

155.02

1938

10698

(3032080) INR in Blood by Coagulation assay

2092

13198

2.76

153.45

13.5

20.0

1.25

1.38

inr

15.02

1756

11088

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

153

200.95

148.17

4.3

2.9

105.99

56.89

pmol/l

—

129

(3010370) Gastrin [Moles/volume] in Serum or Plasma

37.03

144.74

3.1

1.3

34.06

25.12

pmol/l

0.67

(3033658) Prothrombin time (PT) actual/Normal

1194

5930

2.64

140.01

6.9

3.7

77.63

83.90

16.17

1178

5793

(3044640) Blood type and Crossmatch panel - Blood

1360

7356

2.50

131.24

3.4

2.2

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

106

17.95

130.45

1.6

1.3

1.75

1.99

umol/l

1.22

101

(3012095) Magnesium [Moles/volume] in Serum or Plasma

900

4071

2.70

125.20

3.4

2.5

0.81

0.82

mmol/l

1.57

865

3749

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1336

7615

2.31

109.38

6.0

2.6

66.65

36.91

u/l

13.90

1292

7075

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1688

10691

2.25

106.07

3.7

2.5

—

estimate

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1935

13143

2.23

99.85

24.2

6.1

4.58

4.44

e9/l

1.36

1726

11122

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

468

10442

0.35

97.90

1.8

2.0

1.40

1.31

mmol/l

1.10

415

8624

(3042936) Bacteria identified in Isolate by Culture

771

3631

2.49

95.25

2.2

2.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1039

5614

2.27

93.45

3.1

2.2

—

(3002256) Pathology report gross observation

459

1777

2.85

83.24

1.5

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

160

301

5.55

81.26

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

973

5427

2.15

78.32

8.1

2.2

2.49

2.45

mmol/l

21.20

935

4767

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1871

23474

0.50

74.56

4.2

5.5

1.35

1.44

mmol/l

14.69

1635

21428

(3023183) Ammonium ion [Moles/volume] in Plasma

218

579

3.97

72.35

1.7

2.4

35.35

34.48

umol/l

0.14

198

512

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1902

23669

0.50

72.19

4.2

5.6

4.31

4.44

mmol/l

5.40

1674

21764

(3015377) Calcium [Moles/volume] in Serum or Plasma

1343

8645

1.97

71.27

9.3

2.2

2.32

2.35

mmol/l

14.33

1282

7545

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1975

24194

0.50

69.14

4.7

6.5

2.48

2.54

mmol/l

2.03

1737

22196

(3023487) Leukocytes [#/volume] in Peritoneal fluid

10.36

65.36

1.5

2.7

6939.19

772.88

e6/l

0.59

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

443

1895

2.56

65.08

1.6

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

677

3490

2.20

64.89

3.5

5.5

0.98

1.04

mmol/l

5.42

647

3195

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

318

1157

2.95

63.93

2.3

1.7

1.79

1.81

ug/l

0.01

288

995

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

266

886

3.19

62.32

2.4

3.0

0.30

0.35

iu/ml

1.96

141

514

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

187

525

3.72

57.18

1.6

1.4

0.71

0.83

nmol/l

1.53

172

435

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1823

22481

0.55

55.85

4.4

5.3

2.09

2.04

mu/l

0.42

1600

20412

(4281824) Cell count and differential, peritoneal fluid

120

7.08

54.70

1.3

1.1

—

(40768804) Tissue Pathology biopsy report

1119

7278

1.84

53.46

2.6

1.7

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

832

4926

1.94

53.27

2.0

1.9

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1840

22538

0.56

53.19

3.8

4.7

1.36

1.27

mmol/l

5.53

1597

20319

(3003694) ABO and Rh group [Type] in Blood

953

5913

1.88

52.79

1.4

1.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

734

4224

1.96

50.77

2.1

1.9

30.40

29.85

1.21

723

4103

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

9.68

50.44

1.3

2.5

30315.82

38715.33

e6/l

0.09

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1652

12207

1.75

49.88

8.3

5.9

1.19

1.21

mmol/l

14.57

1583

11044

(3033799) Differential panel - Peritoneal fluid

9.51

48.97

1.5

1.6

—

(3014007) Fractional oxyhemoglobin in Arterial blood

403

1871

2.32

48.68

9.1

8.8

94.84

93.40

6.32

403

1863

(3013826) Glucose [Moles/volume] in Serum or Plasma

1994

15620

1.76

48.18

8.2

4.8

7.95

6.89

mmol/l

52.65

1938

14816

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2006

23753

0.57

46.56

5.3

5.8

6.79

6.11

mmol/l

45.63

1807

21456

(3024980) IgG subclass 4 [Mass/volume] in Serum

135

353

3.95

45.63

1.4

1.7

0.72

0.96

g/l

1.23

277

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1779

13639

1.70

45.03

9.0

6.2

1.19

1.21

mmol/l

14.14

1540

11668

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

126

317

4.10

44.89

1.4

1.3

1.23

1.40

nmol/l

0.89

113

282

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

180

587

3.19

43.46

1.6

1.5

256.36

26.29

u/ml

2.64

170

557

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1458

18608

0.60

43.12

3.8

4.1

15.06

15.04

pmol/l

0.07

1286

16779

(3044007) Cell count panel - Peritoneal fluid

8.70

42.64

1.3

1.9

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

523

2826

2.02

42.55

9.2

7.5

114.12

121.52

g/l

15.49

512

2762

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

610

3486

1.93

42.17

1.9

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

13.25

39.99

1.2

2.3

3.92

4.97

ug/l

0.46

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

636

3744

1.88

39.93

1.9

1.8

—

(3016502) Oxygen saturation in Arterial blood

551

3095

1.95

39.89

8.8

7.0

96.63

94.95

9.21

537

2983

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2004

23439

0.60

38.70

8.4

7.4

44.78

40.54

mmol/mol

45.95

1860

21627

(3019977) pH of Arterial blood

584

3419

1.87

37.02

8.6

6.9

7.42

0.01

308

1963

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

327

1561

2.22

36.52

10.2

9.3

15.44

16.00

3.23

317

1508

(3027801) Oxygen [Partial pressure] in Arterial blood

584

3445

1.85

36.05

8.6

6.8

13.81

11.43

kpa

21.01

569

3298

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

584

3445

1.85

36.05

8.6

6.8

5.07

5.05

kpa

0.18

568

3302

(3018418) pH of Serum or Plasma

1127

8022

1.63

35.16

5.6

3.5

7.40

1.41

813

5801

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2258

19018

1.67

34.90

25.9

5.7

194.69

77.63

u/l

130.29

2214

17663

(3003396) Base excess in Arterial blood by calculation

575

3418

1.84

34.48

8.6

6.8

0.96

1.13

mmol/l

0.57

503

2785

(3027923) C peptide [Moles/volume] in Serum or Plasma

160

4.84

33.93

1.3

0.97

1.26

nmol/l

1.99

114

(3030467) Casts [#/volume] in Urine by Automated count

1049

7398

1.63

33.62

3.2

0.70

0.48

e6/l

1.80

806

5455

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

311

1504

2.19

33.54

1.7

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

185

709

2.71

33.34

2.0

1.6

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

460

2576

1.92

33.14

7.2

6.7

1.45

1.42

mmol/l

0.26

453

2516

(3000991) Gas panel - Venous blood

436

2417

1.93

32.33

7.7

7.9

—

(3002582) Erythrocytes [#/volume] in Urine

1182

8662

1.59

31.86

3.3

45.28

74.03

e6/l

0.90

930

6624

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

642

4050

1.74

31.12

2.1

2.8

19.02

21.99

6.61

613

3694

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1984

22881

0.64

30.01

39.3

16.1

80.77

73.39

ml/min/173m2

49.87

1878

21196

(3000963) Hemoglobin [Mass/volume] in Blood

2306

25700

0.61

29.80

54.9

24.9

119.81

134.74

g/l

307.65

2265

25287

(3007461) Platelets [#/volume] in Blood

2305

25691

0.61

29.79

54.5

24.7

254.67

239.77

e9/l

14.56

2243

24989

(3010813) Leukocytes [#/volume] in Blood

2306

25696

0.61

29.70

54.4

24.7

7.59

6.83

e9/l

37.65

2233

24867

(3026361) Erythrocytes [#/volume] in Blood

2306

25695

0.61

29.68

54.4

24.7

4.05

4.45

e12/l

216.40

2237

24870

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2306

25694

0.61

29.65

55.4

25.1

36.13

40.11

229.51

2263

25264

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2306

25693

0.61

29.63

54.3

24.6

91.30

91.72

4.32

2266

25267

(3035941) MCH [Entitic mass]

2306

25693

0.61

29.63

54.2

24.6

30.17

30.49

14.44

2266

25270

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

342

1798

2.01

29.43

1.9

1.7

—

(3026782) Osmolality of Urine

764

5117

1.65

29.37

3.1

2.9

536.14

531.14

mosm/kgh2o

0.25

703

4444

(36304419) Bacteria [Presence] in Urine

975

6944

1.59

29.07

3.2

1.15

251.10

estimate

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

668

4396

1.66

27.23

2.1

2.7

2.18

2.26

g/l

3.12

633

3988

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2300

25532

0.63

26.95

47.7

22.1

75.90

83.45

umol/l

16.03

2259

25103

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

111

366

3.11

26.31

6.1

5.9

11.99

12.55

mg/l

0.63

100

339

(3022948) Iron [Moles/volume] in Serum or Plasma

703

4724

1.63

26.26

2.3

2.7

10.36

12.34

umol/l

11.65

675

4310

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

110

362

3.11

26.16

1.1

13.67

62.09

iu/ml

0.77

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

101

336

3.07

23.60

2.7

5.6

2634.88

439.32

iu/ml

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

618

4123

1.62

23.46

3.0

3.1

3.42

2.35

e6/l

1.13

308

2017

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

138

552

2.57

22.83

2.1

236.45

196.08

4.78

127

522

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1765

14715

1.46

22.76

5.3

3.2

230.58

50.13

u/l

67.69

1695

13452

(3012544) pH of Venous blood

496

3157

1.68

22.58

3.2

3.5

7.39

7.38

2.85

303

1839

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

319

3.07

22.49

1.0

1.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

490

3117

1.68

22.34

3.1

3.4

5.59

5.84

kpa

8.19

477

3027

(3018095) Leukocytes [#/volume] in Urine

1234

9637

1.46

22.32

3.8

3.9

65.79

128.33

e6/l

3.66

937

6835

(3017315) Amylase [Enzymatic activity/volume] in Urine

135

4.28

22.07

1.3

1.2

362.27

333.50

u/l

0.06

122

(3002032) Base excess in Venous blood by calculation

480

3048

1.68

22.01

3.1

3.4

2.01

1.91

mmol/l

0.22

413

2649

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

674

9360

0.64

21.96

2.0

2.3

153.89

230.99

u/l

4.19

627

8778

(42870588) Differential panel, method unspecified - Blood

1068

8129

1.48

21.96

5.4

—

(1761868) Lipid panel - Serum or Plasma

522

7664

0.62

21.78

3.3

3.7

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

305

3.04

21.02

1.0

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

334

1972

1.78

19.80

8.7

6.4

24.26

24.51

mmol/l

0.56

321

1892

(3020779) Urea [Moles/volume] in Serum or Plasma

409

2573

1.68

19.28

4.1

6.8

8.78

11.58

mmol/l

11.95

388

2433

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2286

25045

0.68

19.26

29.4

11.0

41.85

25.01

u/l

75.73

2243

23999

(3023103) Potassium [Moles/volume] in Serum or Plasma

2296

25114

0.68

18.88

42.6

21.0

3.95

4.01

mmol/l

19.93

2253

24499

(3024354) Oxygen [Partial pressure] in Venous blood

415

2647

1.65

18.51

2.9

3.0

4.43

kpa

0.01

403

2559

(3019550) Sodium [Moles/volume] in Serum or Plasma

2296

25078

0.68

18.22

42.6

20.9

137.72

139.76

mmol/l

160.86

2253

24510

(3004809) Band form neutrophils/Leukocytes in Blood

299

2.89

18.07

2.4

2.3

1.69

1.31

0.57

247

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

284

1644

1.80

17.96

2.5

2.7

0.70

0.63

2.66

284

1638

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

5.53

17.89

3.0

2.2

1.25

1.31

0.06

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

234

4047

0.54

17.81

1.2

1.3

7.32

14.21

u/ml

1.10

1469

(3002030) Lymphocytes/Leukocytes in Blood

1378

11343

1.38

17.03

5.6

5.7

22.16

26.25

30.51

1323

10604

(3004119) Hemoglobin [Mass/volume] in Venous blood

326

2003

1.70

16.69

3.1

3.0

119.93

129.73

g/l

13.26

319

1946

(3019069) Monocytes/Leukocytes in Blood

1359

11186

1.38

16.68

5.6

5.7

8.93

9.14

1.14

1296

10311

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

263

4312

0.57

16.41

1.2

1.3

33.81

39.63

iu/ml

0.39

1303

(3006922) Hepatitis E virus Ab [Presence] in Serum

139

3.71

16.38

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

654

8732

0.68

16.22

4.1

21.20

24.49

7.18

316

4336

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

317

1953

1.69

16.05

1.3

1.5

—

(3006504) Eosinophils/Leukocytes in Blood

1348

11162

1.36

15.58

5.5

5.6

2.40

2.98

18.13

1286

10296

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

632

4597

1.47

15.46

2.9

3.0

1.52

1.28

e6/l

0.68

328

2510

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

123

564

2.23

15.08

1.4

1.3

—

(40758558) Short blood count panel - Blood

915

7172

1.39

14.65

17.8

4.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

288

1772

1.69

14.63

1.3

1.5

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1912

16801

1.35

14.58

4.8

5.0

267.62

2848.66

e6/l

3.63

278

(3018010) Neutrophils/Leukocytes in Blood

1336

11154

1.34

14.20

5.4

5.6

61.17

58.50

9.93

1291

10521

(3022096) Basophils/Leukocytes in Blood

1338

11175

1.34

14.17

5.6

5.7

0.57

0.66

8.12

1273

10305

(3036489) Thrombin time

156

803

1.99

14.15

1.9

1.8

22.95

20.72

2.66

147

720

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1640

18630

0.75

13.85

3.6

4.5

17.48

13.18

mm/h

17.87

1503

17243

(3020891) Body temperature

249

1497

1.72

13.76

5.7

4.5

36.98

36.92

°c

1.23

249

1481

(3027273) Bicarbonate [Moles/volume] in Venous blood

253

1528

1.71

13.76

3.6

3.0

24.49

25.25

mmol/l

2.55

242

1470

(3019060) Gas panel - Arterial blood

300

1898

1.64

13.68

6.6

4.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

443

6179

0.67

13.32

3.0

0.75

0.74

ug/l

0.10

300

4246

(3007930) Methemoglobin/Hemoglobin.total in Blood

220

1290

1.76

13.29

7.4

4.4

0.89

0.86

0.36

207

1222

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

166

894

1.90

13.20

1.3

1.2

—

(3012501) Base excess in Blood by calculation

114

540

2.15

12.94

5.6

4.6

2.96

2.74

mmol/l

0.36

356

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

322

2104

1.59

12.85

5.9

3.2

1.22

1.23

mmol/l

0.36

302

1766

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1101

13139

0.75

12.68

2.2

2.3

91.03

94.36

pmol/l

1.45

685

6826

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

392

2686

1.53

12.66

3.1

2.3

263.11

234.75

u/l

1.87

376

2481

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

232

1402

1.71

12.59

7.1

4.2

1.67

1.60

0.49

218

1328

(40768795) Lymph node Pathology biopsy report

5.98

12.59

1.2

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

176

3.05

12.56

1.2

10.70

9.65

mmol/l

0.61

163

(3000850) Epithelial cells [#/volume] in Urine

782

6100

1.38

12.56

2.7

2.6

7.36

4.78

e6/l

3.88

730

5519

(40768797) Stomach Pathology biopsy report

485

3480

1.47

12.49

1.3

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

875

10775

0.74

12.45

4.4

4.3

2.52

2.10

ug/l

1.32

743

9681

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

382

2.34

12.33

1.4

1.3

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

124

3.42

12.05

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

116

577

2.05

11.62

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

355

2.35

11.58

1.4

1.5

34.06

27.33

g/l

3.26

311

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

11.46

1.2

0.0

—

(4062490) Immunoglobulin typing, IgG

205

2.76

11.18

1.2

1.5

—

(3039000) Anion gap in Blood by calculation

115

579

2.02

11.15

10.2

5.8

11.04

11.43

mmol/l

0.73

105

522

(3018572) Chloride [Moles/volume] in Blood

115

579

2.02

11.15

10.2

5.9

105.78

104.73

mmol/l

1.48

105

522

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

973

11665

0.76

11.04

2.5

2.4

71.25

79.01

nmol/l

13.92

898

10228

(3035637) Corticotropin [Mass/volume] in Plasma

201

2.77

11.02

2.0

1.5

35.74

20.68

ng/l

1.17

201

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

307

2.41

11.01

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

209

2.71

10.79

1.2

1.5

0.42

0.39

g/l

0.21

154

(3028192) IgG subclass 2 [Mass/volume] in Serum

209

2.71

10.79

1.2

1.5

3.24

3.02

g/l

0.56

154

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

9.60

10.73

1.3

1.0

—

(3012516) Albumin [Mass/volume] in Urine

833

10174

0.75

10.73

3.1

3.5

61.07

47.11

mg/l

0.48

568

6582

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1734

19267

0.78

10.70

48.7

21.6

329.99

331.79

g/l

14.70

1714

19134

(3045788) Cell count panel - Pleural fluid

246

2.55

10.59

1.4

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

270

2.48

10.58

1.3

1.4

30672.09

56873.43

e6/l

0.50

157

(40768800) Prostate Pathology biopsy report

146

3.04

10.49

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

311

2.35

10.26

1.4

1.5

4940.59

1365.63

e6/l

0.79

224

(3027135) IgG subclass 1 [Mass/volume] in Serum

209

2.66

10.25

1.2

1.5

6.18

7.05

g/l

1.15

154

(3045414) Leukocytes [Presence] in Urine

156

2608

0.58

10.21

2.2

2.0

0.00

0.01

estimate

0.78

496

(3047181) Lactate [Moles/volume] in Blood

151

860

1.79

10.11

8.8

5.2

1.55

1.33

mmol/l

1.95

135

761

(3022475) Manganese [Moles/volume] in Blood

26.09

9.81

1.2

1.0

0.14

0.15

umol/l

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

281

2.38

9.73

1.4

—

(40761536) Microorganisms panel - Urine sediment

272

1821

1.54

9.73

4.0

4.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

548

7024

0.73

9.61

2.8

2.6

348.80

361.59

umol/l

1.63

448

5957

(3001604) Monocytes [#/volume] in Blood

1406

12240

1.27

9.58

5.3

5.4

0.64

0.62

e9/l

1.57

1166

10321

(3017181) Myelocytes/Leukocytes in Blood

302

2076

1.50

9.55

2.5

3.8

1.23

0.77

2.52

165

440

(4024509) Urine culture

1414

0.46

9.50

1.8

2.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

113

602

1.91

9.37

1.1

1.2

90.83

113.18

titre

0.36

(3006315) Basophils [#/volume] in Blood

1408

12304

1.26

9.14

5.3

5.4

0.04

e9/l

1.13

1170

10384

(3019198) Lymphocytes [#/volume] in Blood

1424

12518

1.25

8.59

5.5

1.62

1.80

e9/l

7.98

1221

10788

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

173

1081

1.64

8.32

2.0

1.8

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

370

2721

1.41

8.19

5.3

3.4

—

(3026008) Bacteria identified in Urine by Culture

1000

8496

1.26

7.95

3.1

3.5

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

7.24

7.95

1.8

2.2

1.12

1.76

mmol/l

0.27

(3013115) Eosinophils [#/volume] in Blood

1432

12671

1.24

7.90

5.6

0.18

0.21

e9/l

5.44

1208

10843

(3009508) Creatinine [Moles/volume] in Urine

875

10317

0.79

7.87

3.0

3.5

6.83

7.25

mmol/l

2.70

727

8626

(40768806) Pleura Pathology biopsy report

233

2.34

7.80

1.5

1.4

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

166

2.55

7.34

1.7

1.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

+∞

7.29

1.1

0.0

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

173

2.51

7.25

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

173

2.51

7.25

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

173

2.51

7.25

1.2

—

(3045424) Erythrocytes [Presence] in Urine

1270

0.50

7.24

2.3

2.0

0.00

0.66

estimate

0.50

382

(3021960) Folate [Moles/volume] in Serum or Plasma

732

8739

0.79

7.16

1.8

1.7

20.42

20.11

nmol/l

0.24

683

7299

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

242

3387

0.69

7.02

4.1

5.5

33.66

33.34

0.16

147

2149

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

195

2.38

6.95

1.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1433

0.54

6.94

1.2

1.3

16.78

60.02

au/ml

—

105

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

158

1012

1.59

6.91

2.0

1.7

—

(3023420) DNA double strand Ab [Units/volume] in Serum

1018

0.46

6.79

1.5

1.7

7.33

6.50

iu/ml

—

243

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1575

0.57

6.79

2.3

2.5

11.97

20.28

au/ml

—

109

(40768793) Breast Pathology biopsy report

115

2.80

6.73

1.3

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

223

1556

1.47

6.58

1.8

2.3

9.89

10.93

g/l

4.66

191

1420

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

8.70

6.54

1.1

1.3

25.13

15.11

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

140

2.59

6.53

2.9

1.9

16.17

15.85

nmol/l

0.08

121

(3045142) Bone marrow Pathology biopsy report

106

2.85

6.52

1.3

1.1

—

(3035933) Granulocytes/Leukocytes in Blood

411

1.90

6.46

3.9

3.1

59.44

59.32

0.03

411

(3002179) Metamyelocytes/Leukocytes in Blood

273

1988

1.41

6.39

2.4

3.5

0.76

0.59

0.57

144

425

(3008757) Leukocyte morphology finding [Identifier] in Blood

192

2.31

6.26

2.3

2.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

180

2.35

6.23

3.3

1.6

7.97

8.33

mmol/l

0.30

180

(3025941) Bacteria identified in Stool by Culture

169

1132

1.52

6.10

1.3

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

12.53

6.08

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

121

751

1.64

6.06

4.8

4.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

776

0.43

5.89

1.6

1.5

24023.35

13316.85

e6/l

0.35

549

(44790047) Parainfluenza type 1 nucleic acid detection

284

2.03

5.86

1.5

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

284

2.03

5.86

1.5

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

284

2.03

5.86

1.5

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

284

2.03

5.86

1.5

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

148

2.45

5.86

1.8

1.6

5011.96

1192.21

u/l

0.33

(3021440) Promyelocytes/Leukocytes in Blood

273

2023

1.38

5.78

2.5

3.8

0.24

0.06

3.07

138

389

(40760892) CBC W Ordered Manual Differential panel - Blood

587

4841

1.26

5.77

3.8

4.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

342

1.92

5.73

1.1

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

161

1083

1.51

5.72

1.2

1.4

—

(3035715) Granulocytes [#/volume] in Blood

350

1.90

5.69

3.4

3.2

4.57

4.50

e9/l

0.07

350

(3020682) Albumin/Creatinine [Ratio] in Urine

910

10405

0.82

5.61

3.8

4.2

9.99

8.34

mg/mmol

0.46

590

6542

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

297

1.97

5.55

1.1

1.4

172.11

157.57

au/ml

0.61

108

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

140

2071

0.66

5.43

1.3

1.5

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

281

2116

1.36

5.40

2.6

1.8

424.16

371.97

nmol/l

3.04

263

1912

(3038177) Helicobacter pylori Ab [Presence] in Serum

294

1.96

5.35

1.4

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

2.87

5.35

1.1

1.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

226

2.10

5.34

3.0

—

(1616796) Gas panel - Central venous blood

605

1.66

5.31

3.7

4.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

241

2.05

5.25

1.9

1.2

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

4.59

5.17

1.1

1.3

22.00

1157.90

u/l

0.48

(3037522) Nuclear Ab [Titer] in Serum

243

3221

0.73

5.07

1.2

1.3

517.60

541.63

titre

0.06

749

(3012441) Differential panel - Pleural fluid

260

1.98

4.97

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

844

0.50

4.95

1.2

1.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

112

1699

0.65

4.92

2.1

2.2

12.15

15.02

nmol/l

3.59

100

1518

(3021788) Differential panel - Synovial fluid

540

0.38

4.90

1.9

1.4

—

1.00

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

707

0.46

4.90

1.2

—

43.55

—

(3043410) Blood group antigens tested for on Red Blood Cells

3.23

4.89

1.7

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

163

2.22

4.78

1.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

500

1.68

4.74

1.5

1.3

—

(3008898) HLA-B27 [Presence]

559

0.41

4.72

1.0

1.1

—

(3025159) Blasts/Leukocytes in Blood

268

2050

1.34

4.66

2.5

3.9

0.11

0.01

0.98

130

362

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

158

2216

0.70

4.65

1.4

—

(3035880) pH of Pleural fluid

121

2.41

4.63

1.1

1.3

7.37

7.45

1.37

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

591

1.61

4.56

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

591

1.61

4.56

1.3

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1779

18991

0.85

4.50

47.8

19.8

15.02

13.73

167.40

1763

18655

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

441

1.69

4.42

1.4

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.69

4.41

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

359

1.77

4.41

1.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1067

11838

0.85

4.37

2.7

2.4

—

(3017354) Segmented neutrophils/Leukocytes in Blood

210

2.01

4.36

1.7

2.3

67.58

60.56

1.33

166

(4094501) Cardiovascular stress test using bicycle ergometer

749

0.51

4.25

1.2

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

2.70

4.25

1.6

2.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

810

0.54

4.19

1.2

1.5

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

292

1.83

4.16

1.6

1.3

0.20

nmol/l

0.12

253

(3000492) Spirometry study

152

2099

0.71

4.11

1.4

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

490

1.63

4.08

1.5

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

287

1.83

4.06

1.0

1.1

1.83

1.54

g/l

2.56

249

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

303

1.80

4.01

1.7

1.3

—

nmol/l

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

283

3554

0.78

4.00

13.4

7.7

—

(3044941) Cell count panel - Synovial fluid

533

0.45

3.99

1.5

1.4

—

(1002224) Polysomnography panel

766

0.54

3.90

1.0

1.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

153

2090

0.72

3.89

1.8

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.57

3.88

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.57

3.88

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.57

3.88

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

440

0.41

3.81

1.7

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

907

10105

0.86

3.77

2.7

3.4

1401.28

1707.36

ng/l

1.23

814

8802

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

127

2.22

3.76

1.4

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

134

2.18

3.73

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

148

2.11

3.68

1.3

—

(3013637) Mi-2 Ab [Presence] in Serum

0.00

3.65

0.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.00

3.65

0.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.00

3.65

0.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.00

3.65

0.0

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

234

0.30

3.57

1.0

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

819

0.58

3.54

3.0

3.4

0.75

0.84

nmol/l

1.86

659

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

346

1.69

3.52

1.7

1.3

0.59

5.77

nmol/l

0.51

333

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.77

3.42

1.1

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

427

1.61

3.40

1.5

1.3

—

(3023410) Appearance of Cerebral spinal fluid

208

0.29

3.34

1.2

1.5

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

0.00

3.31

0.0

1.1

—

2.29

—

(3011648) Oxygen content in Venous blood

277

1.74

3.30

1.5

1.9

11.26

10.16

0.98

277

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

241

0.33

3.29

1.0

1.1

—

78.25

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2294

23816

0.86

3.26

38.9

16.4

40.24

25.91

mg/l

64.39

2230

19678

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

0.00

3.14

0.0

1.2

—

10.62

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

2.41

3.13

1.5

3.68

4.40

mg/l

0.43

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.47

3.12

1.3

2.2

0.60

0.61

mmol/l

0.41

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

256

2070

1.26

3.00

5.9

2.4

72.55

61.15

ml/min/173m2

3.47

128

857

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

119

866

1.39

2.95

1.7

1.5

34.60

26.03

u/ml

0.34

143

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

279

0.36

2.92

1.0

1.1

—

52.61

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

2.44

2.87

1.9

2.2

43.78

46.38

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1065

0.68

2.77

1.2

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

202

1.79

2.77

1.2

1.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

3.08

2.77

1.1

1.0

—

(3000330) Specific gravity of Urine by Test strip

191

1507

1.28

2.76

4.0

3.6

1.02

ratio

4.69

178

1374

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

356

1.58

2.73

1.7

1.3

0.15

0.35

nmol/l

—

(3019309) Folate [Moles/volume] in Red Blood Cells

510

5804

0.86

2.68

1.8

1191.51

1160.05

nmol/l

0.34

406

4384

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

265

0.38

2.65

1.0

1.1

3.19

1.63

u/ml

—

137

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

389

0.49

2.64

1.1

1.2

1.53

1.52

g/l

0.03

389

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

123

920

1.35

2.61

2.6

2.8

—

(40768443) Skin Pathology biopsy report

1004

0.68

2.61

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.34

2.60

1.1

—

(3021589) Normoblasts [#/volume] in Blood

1142

10581

1.12

2.56

21.3

10.6

0.00

e9/l

3.19

896

8559

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

818

7425

1.14

2.56

2.2

2.4

3.00

2.84

mg/l

1.23

727

6354

(3006571) Granulocytes/Leukocytes in Synovial fluid

343

0.46

2.54

1.7

1.5

68.56

62.57

—

226

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1227

0.72

2.49

1.7

1.4

7.45

7.53

g/l

0.16

1088

(21494755) Public health laboratory ask at order entry panel

1018

0.69

2.49

1.2

1.4

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1226

0.72

2.48

1.7

1.4

4.09

4.20

g/l

0.58

1090

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

237

1945

1.24

2.48

3.3

3.7

4.99

5.19

kpa

2.86

221

1842

(3048929) Epstein Barr virus Ab [Presence] in Serum

430

1.50

2.47

1.1

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

366

1.54

2.46

7.0

27.2

9.04

7.62

mmol/l

1.52

303

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.46

2.44

1.1

1.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

158

1239

1.29

2.43

1.5

1.4

1.07

1.17

g/l

0.49

146

1124

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1151

0.71

2.42

1.7

1.4

3.04

2.92

g/l

0.56

1013

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

976

0.69

2.41

1.7

1.9

39.02

38.35

u/l

0.09

830

(3017569) Oxygen content in Arterial blood

197

1.73

2.39

4.0

1.8

12.76

16.39

9.77

197

(3034860) Kappa light chains.free [Mass/volume] in Serum

1009

0.70

2.39

1.7

1.5

46.70

48.42

mg/l

0.09

852

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

710

1.38

2.38

1.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1007

0.70

2.36

1.7

1.5

29.61

35.20

mg/l

0.93

846

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1050

0.71

2.32

1.8

1.5

0.90

0.38

g/l

1.16

897

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

203

1651

1.25

2.32

3.2

3.5

2.09

2.00

mmol/l

0.09

136

1207

(3009343) pH of Capillary blood

229

1888

1.23

2.31

3.3

3.7

7.42

7.41

0.53

197

1561

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

245

1.64

2.31

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

162

1.80

2.31

1.4

1.3

12.03

14.43

u/l

1.53

154

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1221

0.73

2.30

1.7

1.4

3.62

3.76

g/l

0.43

1082

(3038026) Centromere Ab [Units/volume] in Serum

200

0.40

2.29

1.0

1.1

—

59.40

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

272

2285

1.21

2.28

1.5

1.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

894

0.69

2.27

1.7

1.5

1.35

1.66

ratio

1.29

525

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

2.16

2.24

2.2

1.7

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

399

1.49

2.24

1.1

1.2

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.69

2.20

1.1

1.3

0.53

1.57

mmol/l

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

2.78

2.13

1.4

9.00

8.95

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

704

0.66

2.11

1.7

1.5

19.74

4.79

iu/ml

0.34

144

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

332

0.51

2.11

1.1

1.2

0.72

0.64

ratio

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

316

1.53

2.08

1.1

1.2

284.81

273.36

u/ml

0.09

184

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

0.00

2.06

0.0

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.08

2.06

1.5

2.7

10.37

9.73

kpa

0.67

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.08

2.06

1.5

2.7

4.66

5.09

kpa

1.32

(3033099) Centromere Ab [Titer] in Serum

0.00

2.05

0.0

1.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

637

5772

1.13

2.02

3.7

4.4

88.98

419.19

ng/l

11.50

518

4957

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.41

2.02

1.2

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.08

2.01

1.3

1.5

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

232

0.43

2.01

1.0

1.1

—

0.28

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

126

1.83

1.98

1.7

1.5

—

(3019150) Specific gravity of Urine by Refractometry

581

6419

0.88

1.97

4.0

4.5

1.02

1.26

kg/l

0.50

405

4237

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.29

1.97

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.29

1.97

1.1

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

256

0.47

1.94

1.5

1.4

25.23

27.15

—

170

(3020393) Adenovirus Ag [Presence] in Stool

3.75

1.93

1.0

—

(21494814) CD8 cells/Lymphocytes in Specimen

2.45

1.93

2.0

2.4

33.73

26.13

1.15

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

185

0.43

1.92

1.0

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.12

1.92

1.8

1.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

294

0.51

1.91

1.5

1.8

18.00

25.99

u/ml

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

827

0.71

1.90

2.2

1.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

220

1.60

1.87

1.2

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

291

0.51

1.86

1.3

2916.50

139379.90

e6/l

—

201

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

742

0.70

1.85

2.2

1.6

—

(3004451) EKG impression Narrative

190

1.64

1.84

1.1

1.3

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

2.27

1.80

1.1

1.3

1.46

1.27

mmol/l

—

(3014051) Protein [Presence] in Urine by Test strip

630

6891

0.89

1.80

3.2

0.14

0.05

0.52

251

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1216

0.77

1.80

1.2

194.59

113.37

u/ml

0.97

451

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

395

1.43

1.77

1.3

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

273

0.51

1.77

1.0

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

219

0.45

1.76

1.0

1.1

—

26.86

—

(3017732) Neutrophils [#/volume] in Blood

255

2961

0.85

1.76

6.2

2.9

4.76

4.73

e9/l

0.03

219

2463

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

231

0.47

1.73

1.1

—

(44806420) Estimation of glomerular filtration rate

217

1.57

1.73

2.4

2.6

—

(3004616) Nuclear Ab [Presence] in Serum

322

0.56

1.73

1.3

1.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

566

0.67

1.72

1.1

1.2

—

316.36

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

509

1.36

1.70

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1071

0.76

1.70

1.8

1.4

10.14

10.21

g/l

0.06

927

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

172

1.63

1.67

1.2

1.3

19.09

10.51

u/l

0.86

150

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

489

0.65

1.65

1.1

1.4

—

10.32

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

239

0.50

1.64

1.2

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1031

0.76

1.64

1.1

1.2

—

(3008295) Osmolality of Serum or Plasma

277

1.49

1.64

1.3

1.4

273.13

274.39

mosm/kgh2o

0.16

203

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

147

0.41

1.64

1.5

1.1

84.10

36.48

mg/l

—

126

(3024263) Appearance of Synovial fluid

149

0.40

1.63

1.0

1.6

—

(3003181) Sodium [Moles/volume] in Urine

575

1.33

1.61

1.3

1.4

61.84

59.95

mmol/l

0.13

463

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

255

2933

0.86

1.58

2.2

2.5

3.71

7.52

ug/l

12.34

220

2545

(3020876) Protein [Mass/time] in 24 hour Urine

324

0.58

1.56

1.8

2.0

1.74

1.38

g/24h

—

168

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

298

1.45

1.53

1.3

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

703

1.29

1.53

4.7

3.7

2.02

1.61

index

0.38

351

(3016750) Collection duration of Urine

153

1.64

1.53

2.2

1.9

434.76

493.89

min

1.16

110

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1030

10912

0.92

1.52

2.7

3.1

240.88

137.74

ug/l

12.13

958

9979

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

232

0.52

1.52

1.0

1.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.60

1.51

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

0.00

1.51

0.0

2.0

—

8.88

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

108

1.76

1.50

1.1

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

882

0.75

1.50

1.9

1.4

0.10

0.01

g/l

0.80

798

(3004775) Volume in Urine collected for unspecified duration

234

1.50

1.49

2.3

2.2

794.39

616.50

0.74

145

(3052592) Norovirus Ag [Presence] in Stool

2.07

1.49

1.3

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.00

1.48

1.1

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

368

0.62

1.48

1.1

1.5

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

2.37

1.45

2.0

1.6

29.96

56.36

u/l

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

198

1694

1.18

1.44

1.2

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

302

1.43

1.44

1.3

1.2

—

(3035350) Ketones [Presence] in Urine by Test strip

1313

13742

0.92

1.43

3.9

4.1

11.86

3.04

estimate

0.68

336

2839

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

339

0.62

1.41

1.0

1.1

—

16.22

—

(3042631) Mycobacterium sp identified in Specimen

337

1.40

1.41

2.1

3.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

535

1.32

1.41

1.2

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

305

1.42

1.38

1.3

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.94

1.36

1.2

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

583

0.72

1.35

1.7

1.8

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

844

0.77

1.35

2.0

1.4

0.03

0.00

g/l

0.49

746

(3014765) Yersinia sp identified in Stool by Organism specific culture

637

1.28

1.34

1.2

1.1

—

(3019225) pH of Specimen

296

2630

1.14

1.32

4.0

3.9

7.36

0.04

257

1727

(3009015) Lactate [Moles/volume] in Synovial fluid

0.00

1.31

0.0

1.2

—

7.46

—

(42529406) Shigella sp [Presence] in Stool by Culture

640

1.27

1.30

1.2

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.36

1.29

1.1

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

224

2556

0.87

1.28

1.4

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.78

1.28

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.78

1.28

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.78

1.28

1.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

171

1.52

1.23

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

200

0.55

1.19

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.31

1.18

1.3

1.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

782

0.78

1.18

1.1

1.5

—

19.37

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

633

1.25

1.16

1.2

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

0.00

1.16

0.0

1.1

—

3.33

—

(3009261) Glucose [Presence] in Urine by Test strip

1328

13812

0.93

1.15

3.9

4.2

0.00

0.02

estimate

1.65

308

2607

(3021601) Nitrite [Presence] in Urine by Test strip

1302

13549

0.93

1.14

3.9

4.1

0.00

estimate

0.42

328

2741

(3044927) Protein electrophoresis panel - Urine

366

0.68

1.12

1.2

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

113

0.44

1.12

1.0

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

167

1.50

1.12

1.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

798

0.79

1.12

2.0

1.5

0.00

g/l

-0.00

744

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

285

1.37

1.10

1.4

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

2.26

1.10

1.1

51.71

66.13

ug/l

—

(3032057) Clostridioides difficile [Presence] in Stool

1.82

1.09

1.5

1.8

—

(44813793) Dust mix specific IgE antibody measurement

140

0.50

1.09

1.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

513

0.74

1.08

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

859

0.80

1.07

1.5

0.34

0.33

mg/l

0.03

375

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

186

1.46

1.06

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

556

0.75

1.05

1.9

1.8

2.51

14.37

iu/l

0.57

216

(3005988) Vibrio sp identified in Specimen by Organism specific culture

288

1.36

1.05

1.4

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

124

0.48

1.04

2.8

5.1

—

65.67

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.06

1.03

1.9

1.6

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

263

2364

1.12

1.02

2.5

2.3

0.81

0.46

e6/l

1.13

254

2264

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

646

1.23

1.00

2.5

2.6

1.50

1.83

mg/l

3.45

553

(3020491) Glucose [Moles/volume] in Blood

197

1.43

0.99

1.9

2.5

7.73

6.95

mmol/l

0.51

129

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.71

0.98

1.2

1.6

1870.46

73.33

nmol/24h

0.92

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

133

0.53

0.98

1.0

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

0.00

0.97

0.0

1.1

—

5.16

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.00

0.97

0.0

1.8

—

17.89

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.85

0.96

1.1

1.2

967.80

244.83

pmol/l

—

(3000093) Morphology [Interpretation] in Blood Narrative

241

1.37

0.96

1.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

328

2999

1.10

0.95

1.7

1.8

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

560

1.24

0.95

1.3

1.6

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

285

1.34

0.94

1.4

1.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1178

11328

1.06

0.94

4.1

4.3

36.73

90.24

ng/l

2.28

987

8813

(3039162) Centromere protein B Ab [Units/volume] in Serum

301

0.70

0.89

1.2

—

62.10

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

128

1.49

0.85

1.3

1.8

1.08

1.96

u/field

0.55

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

1.67

0.85

1.2

14.83

10.07

mm/h

0.63

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

237

2146

1.11

0.85

1.4

1.8

1.66

1.57

0.60

194

1823

(4034850) Laboratory test

918

0.83

13.6

10.9

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

112

0.53

0.83

1.2

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

114

0.53

0.82

1.0

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

177

0.62

0.81

1.0

1.2

2.78

2.29

mmol/l

0.68

164

(3011985) Renin [Units/volume] in Plasma

364

1.27

0.81

1.6

1.4

40.28

81.14

mu/l

1.33

331

(3006184) Hemoglobin [Mass/volume] in Capillary blood

729

1.18

0.80

2.4

2.2

114.06

130.85

g/l

7.70

579

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

115

999

1.16

0.79

3.2

4.0

24.39

24.79

mmol/l

0.58

101

896

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

270

0.70

0.79

3.1

1.7

—

(4268621) Lupus anticoagulant assay

223

0.67

0.78

2.1

2.3

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

0.00

0.78

0.0

1.1

—

32.13

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

122

0.57

0.78

2.0

2.4

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

0.50

0.77

1.8

1.1

0.54

0.48

ratio

—

(4195642) Thrombophilia screening test

278

0.72

0.74

1.2

—

(3014891) Appearance of Pleural fluid

1.84

0.73

1.1

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

389

1.24

0.71

1.2

1.1

—

0.77

—

(3015736) pH of Urine

1052

10888

0.95

0.71

3.5

3.7

6.23

6.28

0.89

614

5904

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.58

0.71

1.1

—

(40765096) Chromosome analysis panel by Banding

1.92

0.70

1.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.92

0.70

1.4

1.1

—

(36660697) Celiac disease serology panel - Serum

159

1769

0.89

0.70

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

244

2655

0.91

0.70

1.7

2.2

138.23

171.63

ug/g

0.78

198

2093

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.85

0.68

1.0

1.1

84.66

170.36

ng/l

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

603

6330

0.94

0.68

1.7

1.8

15432562.01

33256418.27

pmol/l

0.52

486

5172

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

121

0.58

0.67

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

224

2439

0.91

0.66

1.7

1.6

63.97

66.43

g/l

4.19

200

2179

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

0.53

0.66

1.2

1.1

1.05

1.07

ratio

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.61

0.65

3.6

1.8

0.63

1.08

ug/l

—

(3022313) Gas panel - Capillary blood

147

1321

1.12

0.65

3.2

3.8

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

138

1.38

0.62

1.4

13.33

7.32

u/l

0.35

117

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

1.55

0.62

1.2

1.4

15.10

15.68

pmol/l

0.15

(3041096) Erythrocytes [Presence] in Urine by Automated

711

6822

1.05

0.61

3.9

3.6

0.02

0.14

estimate

0.48

268

2108

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

301

0.76

0.61

3.0

3.8

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.60

0.0

1.0

—

88.00

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.57

0.60

2.0

1.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.60

0.0

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

847

1.14

0.58

1.4

1.2

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

1.51

0.58

1.0

1.3

2.99

2.87

umol/l

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

193

1.30

0.57

1.0

1.1

—

(3028433) Virus identified in Specimen by Culture

1.54

0.55

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

632

6579

0.95

0.54

3.4

4.1

0.27

0.19

0.12

(3000034) Microalbumin [Mass/volume] in Urine

267

1.24

0.54

2.4

3.0

20.50

28.81

mg/l

0.44

203

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

360

0.80

0.53

1.9

2.1

13.44

20.81

mg/l

—

110

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

205

1.27

0.52

1.0

1.1

7.42

2.08

eliau/ml

—

(3027945) Reticulocytes/Erythrocytes in Blood

366

3464

1.06

0.52

2.2

2.0

1.94

1.77

1.48

343

3027

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.50

0.51

1.0

—

683.33

—

(3017704) Immunofixation for Urine

154

0.71

0.47

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

749

1.12

0.46

2.6

2.2

105.48

112.57

ug/min

0.08

435

(3006270) Folate [Moles/volume] in Blood

245

1.23

0.46

1.2

452.48

346.07

nmol/l

1.31

200

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

221

0.77

0.46

1.0

1.2

—

(3037756) Immunofixation for Serum or Plasma

557

0.86

0.45

1.1

1.2

—

(3036603) Volume of Urine

156

1.28

0.45

1.3

1.5

1900.20

1875.21

0.06

149

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

186

0.75

0.44

1.0

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

339

1.18

0.44

1.5

1.3

284.91

302.37

pmol/l

0.15

288

(3014271) Vancomycin [Susceptibility]

175

1.26

0.43

2.7

3.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

208

2219

0.93

0.43

3.5

3.8

79.00

98.07

ng/l

2.96

174

1866

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.61

0.43

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

304

1.19

0.42

1.2

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

167

1.26

0.41

2.6

2.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.36

0.41

1.5

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.36

0.41

1.5

1.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.38

0.41

1.8

2.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

240

1.21

0.41

2.2

2.1

1.06

1.37

u/field

0.34

133

(40758292) HTLV I+II Ab panel - Serum

0.00

0.41

0.0

1.1

—

(3003577) Lead [Moles/volume] in Blood

0.00

0.41

0.0

1.1

—

0.12

—

(3020618) Glucose [Moles/volume] in Synovial fluid

0.00

0.41

0.0

1.1

—

7.30

—

(3023419) Bacteria identified in Sputum by Culture

391

0.84

0.41

1.9

2.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

477

4959

0.96

0.41

1.2

1.3

2.90

1.57

u/ml

0.50

111

1274

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.36

0.41

1.8

2.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

186

1.24

0.40

1.2

1.3

124.26

101.92

pmol/l

0.72

186

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.39

0.0

1.3

—

(3019174) dRVVT (LA screen)

0.00

0.39

0.0

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

137

0.73

0.39

1.0

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

258

0.81

0.38

1.6

1.2

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

203

0.79

0.38

1.0

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

290

0.83

0.37

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.35

0.37

2.2

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

592

1.12

0.36

1.4

1.5

—

(3022621) pH of Urine by Test strip

201

2128

0.94

0.35

2.9

5.98

6.07

0.82

163

1507

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

126

1.27

0.35

1.2

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

447

0.87

0.34

1.4

—

(3036048) Francisella tularensis Ab [Titer] in Serum

1.33

0.33

1.0

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

133

0.75

0.33

1.1

1.2

136.40

139.11

nmol/l

—

133

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

109

1.29

0.33

1.3

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

109

1.29

0.33

1.3

1.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

177

0.79

0.33

1.0

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.71

0.30

1.0

1.2

—

(3049717) Cytology report of Urine Cyto stain

918

1.08

0.30

2.8

1.8

—

(3002619) Bacteria identified in Specimen by Culture

1.27

0.30

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

194

0.82

0.27

1.0

1.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

1.25

0.27

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.25

0.27

1.5

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

139

0.79

0.27

1.0

1.1

—

(3000012) Reticulocyte production index

395

1.12

0.26

1.6

0.93

0.88

0.21

254

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

138

0.80

0.25

1.0

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

192

0.83

0.25

1.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

192

0.83

0.25

1.0

1.1

—

(3025130) Human papilloma virus identified in Specimen

158

0.82

0.23

1.4

1.9

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

317

0.88

0.23

2.5

1.8

—

(3018133) Calcium [Moles/volume] in Urine

1.28

0.23

1.4

2.0

2.91

2.73

mmol/l

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.22

0.22

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.22

0.22

2.2

1.6

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.19

0.21

1.0

1.2

18.78

46.17

mg/l

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.5

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.21

0.0

7.5

—

104.70

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.21

0.0

1.4

—

(3035082) Kappa light chains [Mass/volume] in Urine

0.00

0.21

0.0

1.0

—

0.02

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3047189) Immunofixation for 24 hour Urine

104

0.77

0.21

1.0

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.00

0.21

0.0

1.7

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.20

0.0

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.20

0.0

1.9

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.16

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.20

0.0

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1.25

0.20

1.2

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

1.22

0.20

1.3

1.1

—

(3006462) Nitrate [Presence] in Urine

122

0.82

0.19

1.9

3.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.15

0.19

1.0

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

115

1205

0.95

0.18

2.8

3.0

4.13

4.42

pmol/l

2.54

102

1052

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

153

0.85

0.18

3.2

4.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

979

0.95

0.17

1.0

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.15

0.17

1.0

1.2

—

(40757373) Influenza virus identified in Isolate

1.15

0.17

2.0

1.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

163

0.86

0.17

1.2

1.9

83.21

95.26

umol/l

0.96

163

(3051101) Glucose [Moles/volume] in Cord blood

1.11

0.17

3.7

6.9

10.21

8.35

mmol/l

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.76

0.17

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

318

0.91

0.15

1.2

219.05

202.68

miu/ml

—

115

(3003327) Ova and parasites identified in Stool by Light microscopy

657

0.94

0.15

1.5

1.6

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

182

0.88

0.15

1.0

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

134

1390

0.96

0.15

1.5

1.6

1.66

1.55

g/l

0.67

115

1193

(4146454) Self-monitoring of blood glucose

358

0.92

0.14

2.6

2.7

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

103

1.17

0.13

1.6

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

199

1.11

0.13

1.0

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

117

0.85

0.13

1.2

2.1

—

(3016879) Cocaine [Presence] in Urine

242

0.91

0.13

1.2

1.8

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

281

2753

1.02

0.12

2.7

3.4

186.06

235.70

ng/l

1.57

260

2545

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

105

1.14

0.11

1.0

1.1

—

(3022145) Colonoscopy Study observation

244

2485

0.98

0.10

1.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

516

1.05

0.09

1.1

7.73

8.20

eliau/ml

—

(4133840) Spirometry

1.06

0.09

1.4

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.04

0.09

1.0

1.1

—

(3024932) HLA-DR beta [Type]

1.04

0.09

1.2

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

227

0.92

0.09

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.07

0.08

1.7

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

107

1.12

0.08

1.3

153.08

172.00

mmol/24h

0.47

107

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1020

10265

0.99

0.08

4.2

0.04

0.09

estimate

0.47

283

2227

(3003740) Influenza virus B Ag [Presence] in Specimen

226

0.93

0.08

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.77

0.08

3.0

1.5

—

(4211845) Urine protein measurement

133

0.90

0.07

2.0

3.5

—

(3020650) Glucose [Presence] in Urine

0.86

0.07

2.2

1.7

0.00

0.09

estimate

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.83

0.07

10.8

7.4

4.42

5.19

kpa

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

549

5441

1.01

0.07

1.7

3.24

1.38

mg/l

6.14

460

4268

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

264

1.06

0.07

1.1

—

(4015189) Microbial culture of sputum

0.85

0.07

2.0

2.5

—

(21491868) Cryoglobulin [Mass/volume] in Serum

0.84

0.07

1.4

1.3

—

0.06

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

0.87

0.06

1.0

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

103

0.87

0.06

1.0

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

314

0.95

0.05

1.1

1.2

6.10

3.22

u/ml

—

104

(3037121) Protein [Mass/volume] in Urine

879

0.98

0.05

2.2

2.6

302.05

419.36

mg/l

0.51

319

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

150

1478

1.02

0.05

2.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

414

4111

1.01

0.04

1.4

1.3

2.61

2.72

g/l

0.56

249

2283

(3000494) Fungus identified in Specimen by Culture

296

2942

1.01

0.03

1.8

1.5

—

(21494434) Karyotype in Bone marrow

122

1.07

0.02

1.2

1.1

—

(3023520) Reticulocytes [#/volume] in Blood

271

2694

1.01

0.02

2.0

2.1

72.11

67.95

e9/l

0.75

203

2011

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

339

0.97

0.02

1.6

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

308

0.97

0.02

1.0

1.2

2.36

6.51

u/ml

1.98

146

(3029937) Albumin [Presence] in Urine by Test strip

781

7825

1.00

0.01

3.9

4.3

0.00

estimate

0.69

267

2481

(3027944) Amphetamines [Presence] in Urine

254

1.02

0.00

1.2

1.6

—

(3000764) Benzodiazepines [Presence] in Urine

256

0.98

0.00

1.2

1.8

—

(3028300) Cannabinoids [Presence] in Urine

259

1.00

0.00

1.2

1.7

—

(3011288) Drugs identified in Urine by Screen method Nominal

168

1.01

0.00

1.2

2.8

—

(3027008) Opiates [Presence] in Urine

258

1.01

0.00

1.2

1.7

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

593

0.99

0.00

3.5

4.0

41.46

29.74

mg/l

1.56

443

(3032773) Endomysium IgG Ab [Titer] in Serum

193

0.98

0.00

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

197

1.02

0.00

1.2

1.8

—

(3042517) Benzodiazepines panel - Urine

0.00

0.0

1.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

0.86

0.00

12.0

7.6

9.18

10.15

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.4

—

354.00

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

0.95

0.00

1.0

1.2

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

2.16

—

(3013762) Body weight Measured

0.00

0.0

1.6

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

-0.00

0.0

1.1

—

1.36

—

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.3

—

(3034426) Prothrombin time (PT)

0.94

-0.00

1.2

1.3

32.83

29.13

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

1.40

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

1.62

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

4.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

-0.00

0.0

1.0

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

2.7

—

2.88

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.89

-0.00

1.0

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.01

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(3045462) Protein/Creatinine [Ratio] in Urine

0.00

-0.00

0.0

5.3

—

45.31

—

(3024471) HLA-A [Type]

1.02

-0.00

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.8

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

292.60

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

5.17

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.94

-0.00

1.0

1.6

1.16

1.17

mmol/l

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

-0.00

0.0

4.7

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

1352.00

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

0.96

-0.00

1.4

1.3

—

64.00

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

-0.00

0.0

1.6

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_PANCREAS – Malignant neoplasm of pancreas

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of pancreas

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of pancreas (C3_PANCREAS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints